Podcasts about nih

This episode, recorded live at the Becker's 13th Annual CEO + CFO Roundtable, features Shirin Hasan, Research Manager at Endeavor Health, as she discusses managing large-scale clinical trials and NIH-funded research across multiple hospitals. She shares insights on improving operational efficiency, leveraging technology and AI, and designing high-impact workflows to enhance both patient care and research outcomes.

Send us a textDr. Brandon Crawford is joined by Samuel Shepherd, a former Department of Defense biochemical engineer who used his expertise in weapons development to reverse-engineer a cure for his own "incurable" bone cancer. They deep-dive into the science of oxidative stress, the hierarchy of antioxidants, and the specific molecule that allows animals like naked mole rats and sharks to resist cancer and aging.Samuel recounts his 2003 diagnosis of polycythemia vera, where his blood pressure reached levels that "pegged" medical monitors at 300 mmHg. After years of grueling phlebotomies, Sam used a screening algorithm to find a commonality among cancer-resistant species. That common thread was Astaxanthin. However, he didn't just find a supplement; he discovered a way to modify the molecule into a glucosidic form that bypasses the body's digestive barriers to target disease at the atomic level.Key TakeawaysThe Root of All Evil: 92% of inflammatory disease deaths are driven by the hydroxyl free radical. By neutralizing this specific ROS, you address the cause of disease (the trunk) rather than just the symptoms.Molecular Saponification: By using a glucosidic "Trojan Horse" delivery, astaxanthin enters cancer cells and converts acidic free radicals into alkaline ions, dissolving the cancer cell membrane in seconds.The Antioxidant Cliff: Natural cellular protection (Glutathione, SOD) fails significantly after age 42 W or 50 M, making external supplementation essential for longevity.Beyond Brain Barriers: Unlike many antioxidants, this specialized form of astaxanthin crosses the blood-brain barrier, allowing it to neutralize neurotoxins linked to Parkinson's and Alzheimer's.ResourcesUse code CRAWFORD at checkout on Valasta.net for a discount on your order.Valasta.net (testimonials, NIH research papers, dosing information)NIH Research Database (search: "NIH + astaxanthin + [disease]")ProQuest Government Research DatabaseLife Extension (publishes astaxanthin research papers)Dr. Fred Bisci (mentioned as colleague)HSCRP (high-sensitivity C-reactive protein) testing for inflammation markersHematococcus Pluvialis (algae source of astaxanthin)Products 528 Innovations Lasers NeuroSolution Full Spectrum CBD NeuroSolution Broad Spectrum CBD NeuroSolution Stimpod STEMREGEN® Learn MoreFor more information, resources, and podcast episodes, visit https://tinyurl.com/3ppwdfpm

Discover all of the podcasts in our network, search for specific episodes, get the Optimal Living Daily workbook, and learn more at: OLDPodcast.com. Episode 3259: Dr Jenny Brockis explains how increasing dietary fiber, especially from foods like broccoli, can help protect the brain from age-related cognitive decline. By supporting healthy gut bacteria that produce anti-inflammatory compounds like butyrate, a high-fiber diet reduces brain inflammation and promotes long-term mental sharpness. Read along with the original article(s) here: https://www.drjennybrockis.com/2018/11/19/broccoli/ Quotes to ponder: "Choosing to eat a high fiber diet will enable you to maintain a healthy population of those gut bacteria whose job is to keep your brain healthy and wise." "While we like to think our superfood heroes will save the world and us, it's often the unsung heroes that actually make the biggest difference." "One medium apple, banana, pear or orange will provide anywhere from 4-6 grams of dietary fiber." Episode references: Butyrate and brain health research (NIH): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477775/ Dennis Burkitt and dietary fiber (via Wikipedia): https://en.wikipedia.org/wiki/Dennis_Burkitt Learn more about your ad choices. Visit megaphone.fm/adchoices

What does abracadabra mean? You've heard magicians in tuxedos say it, as well as children with magic wands. Maybe even in a Disney movie! It feels magical even if you've never stopped to ask why. It's playful, mysterious, and seems to appear at the exact moment something changes. Today, I'm not talking about stage tricks or fairy tales. This is an invitation to reclaim the magic in words. Abracadabra was meant to heal and to shift energy, and offers a powerful doorway back to something ancient and surprisingly scientific. If you've ever felt stuck in the same mental loop, repeating the same old stories about yourself no matter how much inner work you've done, this is for you. The Magical Power of Your Words The words you speak shape your brain, your nervous system, and the life you quietly create every day. This is actually ancient and ties to the secret history of abracadabra. If you could travel back to the Roman Empire in the second century and told someone you were sick, they might prescribe something unexpected: Abracadabra – a word-based or spoken medicine. That’s when the earliest written record of abracadabra appears in a Roman medical text called Liber Medicinalis, written by a physician named Quintus Serenus Sammonicus. His instructions were precise. Write the word ABRACADABRA on parchment or metal. Then write it again below, removing the last letter. Continue line by line until only the letter “A” remains. The finished inverted triangle would be worn on a string around the neck, and was suggested for someone suffering from a fever. As the word diminished, letter by letter, the illness was believed to fade out too. Images of reconstructed abracadabra amulets still exist today and are physical evidence that words were once understood as active forces, rather than passive communication. What Does Abracadabra Mean? There isn't one agreed upon translation, which is common with magical words. Many scholars trace it to Aramaic, a language closely related to ancient Hebrew, with meanings along the lines of “I create as I speak” or “it will be created in my words.” Others interpret the word as “let the thing be destroyed,” which fits the idea of illness shrinking away. There are also connections to Hebrew blessing traditions and to a Gnostic figure named Abraxas. You don't need a perfect translation to grasp the shared belief underneath the theories. Saying something with intention, was believed to create change. Words shaped reality. A Form of Protection Between the third and seventh centuries, abracadabra also became a form of protection against misfortune and unseen forces. It was spoken, worn, and traced as a spiritual shield. Breath and sound were the tools. So when a magician says “abracadabra” before a big reveal, they're unknowingly echoing an ancient understanding. The moment you speak is the moment something shifts. Words are spells, in the past and still today. Ancient cultures all over the world shared this concept. Mesopotamian incantations were used to drive out illness. Egyptian healers combined herbs with spoken formulas. Biblical traditions delivered blessings and curses through speech. To the ancient mind, words were a force. Name something and you gained power over it. Speak a blessing and you invited it closer. Today witches may talk of spells but the vast majority of the population doesn’t go there. However, it does show up and is acceptable when discussing neuroscience, psychology, and neural pathways. The actual mechanism is quite similar. See, the stories you repeat to yourself like, “I always mess things up,” “nothing ever works out,” or “I'm too old,” act like incantations. The charm is created through your own voice, and the impact is on your nervous system. Unfortunately, this type of mantra spoken unconsciously and without intentional crafting, can backfire, and could even prevent growth or improvement. After more than twenty years working with intuition and mindset, I've seen this pattern again and again. Change often doesn't happen until awareness and usage of the language changes. The Neuroscience of Self-Talk Modern psychology has studied self-talk extensively. Self-talk includes the running commentary in your head and the sentences you speak about yourself and your life. Supportive, positive self-talk is consistently linked to lower anxiety, better coping skills, and greater resilience. Harsh, critical self-talk is linked to higher stress, increased worry, and decreased performance. On a brain level, negative language activates threat centers like the amygdala, while balanced, compassionate self-talk engages the prefrontal cortex, the part of the brain responsible for regulation and problem-solving. A fascinating 2024 study from the NIH explored what happens when people hear affirming statements spoken in their own voice. Turns out hearing your own voice activates brain regions tied to identity and personal meaning more strongly than listening to someone else's voice. This helps explain why a single kind sentence you say to yourself can calm your body, while a harsh one can feel crushing. When you speak to yourself, your brain treats it as deeply personal. Neuroplasticity is the brain's ability to change with experience. Every thought or phrase you repeat creates a pathway. Repeat it often enough and that pathway becomes easier to access. Negative Inner Dialogue If your inner dialogue constantly says, “I'm stuck” or “nothing changes,” you're reinforcing that route. When you begin practicing language like, “I'm learning” or “I'm allowed to begin again,” you start forging new trails. At first this might feel uncomfortable, but over time, the brain learns to favor them. In other words, the magic words you repeat most often becomes your reality. That's everyday abracadabra isn't it? Language affects your inner world and shapes how you perceive and interact with others. The brain loves consistency. It filters information to match the story you tell yourself or others. That's how a belief becomes self-fulfilling, not because the universe is against you, but because your nervous system wants coherence. I'm not suggesting any kind of by passing, ignoring reality, or your feelings. However, you can acknowledge reality and still choose language that leaves room for growth. Examples include: “This is hard and I'm learning how to handle it.” “This hurts and I'm allowed to receive support.” “This didn't go how I wanted and I'm still worthy of good things.” A Powerful Use of Words These thoughts or phrasses are still like “abracadabra” because they are a powerful use of words. Ancient healers didn't deny pain or discomfort. They combined practical care with ritual and language and you can do the same. Abracadabra, in its most empowering interpretation, means “I create as I speak.” Every time you describe who you are or want to become, your brain responds and so does the Universe. Possibilities open or close based on the language you choose. Listen to the podcast for the visualization I created to leverage Abracadabra and this idea of diminishing letter by letter to change a situation which updates your inner operating system. As you move through your day, notice how you talk about yourself. You don't need to monitor every word. Just become curious about the ones that feel heavy or limiting. Then, gently replace them with language that aligns with the life you want to create. This is modern magic, neuroplasticity, and a daily practice, all in one exercise . Abracadabra and there you go! Listen to the podcast today at the top of this page or any audio podcast platform. The post Abracadabra: Words You Speak Have the Power to Change Everything appeared first on Intuitive Edge.

Kids grow up so fast, but you've gotta' keep 'em clothed. Can supposedly sustainable children's clothing brands like Hanna Andersson meet the needs of eco-minded parents? Find out what sustainability claims are legit and which ones are just green hooey in our first episode of season nine. Sources The Good Trade: https://www.thegoodtrade.com/features/organic-baby-clothes/Journal of Textile Science and Fashion Technology “mini review”: https://irispublishers.com/jtsft/fulltext/a-review-sustainable-material-selection-for-childrens-wear.ID.000708.php Wirecutter, NYT: https://www.nytimes.com/wirecutter/blog/is-organic-cotton-better-for-the-environment/ The Guardian: https://www.theguardian.com/sustainable-business/2015/mar/20/cost-cotton-water-challenged-india-world-water-day Trustpilot: https://www.trustpilot.com/review/www.hannaandersson.comHanna Anderson FAQ: https://www.hannaandersson.com/faqs.html?srsltid=AfmBOopAQKYHbtsIFFaAR03jx11CxJdcl9_wTxmQbE9j3eE5r9nZPdeS Hanna Anderson sustainability page: https://www.hannaandersson.com/sustainability.html Good On You: https://directory.goodonyou.eco/brand/hanna-andersson NIH: https://pmc.ncbi.nlm.nih.gov/articles/PMC8755403/ Patreon: patreon.com/greeningupmyactInstagram: @greeningupmyactFacebook: Greening Up My ActEmail us with questions: greeningupmyact@gmail.comYouTube: Greening Up My Act

Discover all of the podcasts in our network, search for specific episodes, get the Optimal Living Daily workbook, and learn more at: OLDPodcast.com. Episode 3259: Dr Jenny Brockis explains how increasing dietary fiber, especially from foods like broccoli, can help protect the brain from age-related cognitive decline. By supporting healthy gut bacteria that produce anti-inflammatory compounds like butyrate, a high-fiber diet reduces brain inflammation and promotes long-term mental sharpness. Read along with the original article(s) here: https://www.drjennybrockis.com/2018/11/19/broccoli/ Quotes to ponder: "Choosing to eat a high fiber diet will enable you to maintain a healthy population of those gut bacteria whose job is to keep your brain healthy and wise." "While we like to think our superfood heroes will save the world and us, it's often the unsung heroes that actually make the biggest difference." "One medium apple, banana, pear or orange will provide anywhere from 4-6 grams of dietary fiber." Episode references: Butyrate and brain health research (NIH): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8477775/ Dennis Burkitt and dietary fiber (via Wikipedia): https://en.wikipedia.org/wiki/Dennis_Burkitt Learn more about your ad choices. Visit megaphone.fm/adchoices

Ep. 178 This episode of The Zen Effect Show... Is an invitation to pause, not panic. To breathe. To ground. To remember: we're gonna be alright.This is a full episode of Conscious Takes, where we explore how to discern what we allow into our minds, bodies, and lives from food and media, to culture, relationships, narratives, and fear itself. t's about slowing the signal, noticing the invisible currents that shape us, and reclaiming our agency.WHAT YOU'LL EXPERIENCE IN THIS EPISODEWhy fear reaches the nervous system before truth does, and practical ways to slow it down.- The real facts about ultra-processed foods (CDC, NIH, FDA) presented without panic or sensationalism.- Food myths and social media panic cycles, how to separate what is real from what is fear-mongering. - A step-by-step framework for conscious discernment: D.I.S.C.E.R.N., designed to guide what information, energy, and narratives we allow in.- A cultural moment worth honoring: A Different World sequel, Atlanta production, and the economic and creative impact on the local community.- AI, media literacy, and the power of intentional consumption in a world designed to hijack attention.- Marriage, maturity, and choosing a partnership from presence, not obligation or societal pressure.- Making love cool again, reclaiming the “we” over the “I,” and how to restore it in daily life.WHY THIS CONVERSATION MATTERS Because what we allow in shapes how we perceive ourselves, our relationships, and our communities. Because fear is not neutral, it imprints in the body and mind, influencing our choices and energy. Because moving fast without discernment comes at a cost and our capacity to show up fully.In a culture that profits from panic, discernment becomes liberation. It's how we:- Stay informed without being consumed.- Stay aware without becoming cynical.- Stay loving without being naïve. The most radical act this week may be --- simply to slow down.- Slow your consumption of food.- Slow your consumption of media.- Slow your consumption of fear.This Week's Shout Out : Sprinkles Boutique Cake Artist

On this week's Tech Nation, Moira speaks with Dr. Shana Kelley, President of Bioengineering and Head of Biohub Chicago,  about AI-Powered Biology - what is it? And what could it mean for the future of research? Then, Dr. Harry Selker and Dr. Atul Deshpande of Immediate Therapeutics tell us how they've come up with a speedy intervention for heart attacks. And, what exactly differentiates the NIH, the FDA, and the CDC? We take a closer look at that, and what they have in common.

Last February, Sudip Parikh, CEO of the American Association for the Advancement of Science, issued a dire warning about federal cuts to science, saying the country was on its way to losing its status as a global science leader.Nearly a year later, where does the United States stand with science funding, and what happens next? Sudip Parikh joins Host Flora Lichtman once again to discuss.Guest: Dr. Sudip Parikh is CEO and Executive Publisher of the American Association for the Advancement of Science, based in Arlington, Virginia.Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

BackgroundBioArticles and Papers Discussed“The Theory Behind the Age-Related Positivity Effect,” Andrew Reed and Laura Carstensen, NIH.gov, Sept. 27, 2012.“Investing Without Blind Spots,” Better Vantage podcast, Nov. 12, 2025.“Out of Sight, Out of Market: The IRA Cash Drag,” by Andy Reed et al., Vanguard.com, Sept. 5, 2024.“Advisors and Investors Split on Inflation, Bond Views,” by Xiao Xu and Andy Reed, Vanguard.com, Sept. 12, 2025.“Stress, Debt, and the Power of Planning,” by Anna Madamba and Andy Reed, Vanguard.com, April 9, 2025“Improving Retirement Outcomes by Default: The Case for an IRA QDIA,” by Andy Reed, et al., Vanguard.com, July 2024."Maximizing versus Satisficing: Happiness Is a Matter of Choice," by Barry Schwartz, Andrew Ward, et al., NIH.gov, November 2002.“The Ostrich Effect: Selective Attention to Information,” George Loewenstein and Duane Seppi, CMU.edu, Feb. 11, 2009.“Inside the Minds of Equity Income Fund Investors,” Sharon Hill and Paulo Costa, Vanguard.com, Aug. 26, 2025.“Trading Is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors,” Brad Barber and Terrance Odean, Berkeley.edu, April 2000.Books DiscussedThe Paradox of Choice: Why More Is Less, by Barry SchwartzNudge: Improving Decisions About Health, Wealth, and Happiness, by Richard Thaler and Cass SunsteinThe Elements of Choice: Why the Way We Decide Matters, by Eric JohnsonOther“Was Bogle's Princeton Thesis Eerily Prescient?” by Jess Bebel, Morningstar.com, May 27, 2022. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Is working until 65 actually bad for your health? In this episode, we dig into what the research really says about the link between retirement age and mortality. I share my journey from being obsessed with early retirement to recognizing the deeper value of time freedom, purpose, and creativity in financial planning. We explore how most professionals are actually on track to be wealthier than they realize, how you can use flexible financial strategies to live better now, and how to stop optimizing for being the richest person in the cemetery. Key moments: (02:40) What the NIH research actually says about retirement and mortality (06:01) What people really want isn't early retirement — it's control over their time (10:15) Most professionals are already on track to have "too much" money (25:06) Why chasing passive income is often solving the wrong problem   Like the show? There are several ways you can help! Follow on Apple Podcasts, Spotify or Amazon Music Leave an honest review on Apple Podcasts  Subscribe to the newsletter Join SLP Insiders for student loan loopholes, SLP app and member community Feeling helpless when it comes to your student loans? Try our free student loan calculator Check out our refinancing bonuses we negotiated Book your custom student loan plan Get profession-specific financial planning Do you have a question about student loans? Leave us a voicemail here or email us at help@studentloanplanner.com and we might feature it in an upcoming show!  

Today's Headlines: After two weeks of nationwide protests, Iran looks closer than ever to a regime collapse. The government shut down the internet all weekend, blamed the U.S. and Israel, and threatened retaliation — while Trump publicly backed protesters online, which historically only makes things messier. In the U.S., a 160-year-old synagogue in Jackson, Mississippi was set on fire early Saturday. No one was hurt, a suspect is in custody, and the congregation — which survived a KKK bombing in 1967 — says it will rebuild. Trump also sat down with the New York Times and said the only thing restraining him is “my own morality,” claimed owning Greenland is “psychologically needed for success,” and suggested NATO could be optional. Around the same time, references to his impeachments quietly disappeared from his Smithsonian portrait label. In Minneapolis, tensions escalated after video showed ICE officer Jonathan Ross switching hands to draw his gun before killing Renee Good. Instead of de-escalating, DHS announced hundreds more federal agents, ICE plans to hire 10,000 more officers, and JD Vance promised “door-to-door” deportations, as a Washington Post report detailed ICE's push to churn out violent arrest videos for social media. Trump also failed to convince oil companies to reinvest in Venezuela, then declared a national emergency anyway to shield $2.5 billion in Venezuelan oil revenue, calling it a U.S. national security issue. Finally, courts blocked Trump from freezing $10 billion in welfare funds to blue states and from cutting NIH research grants, while December jobs numbers showed modest growth — data Trump leaked early on social media because, apparently, impulse control is optional. Resources/Articles mentioned in this episode: The Atlantic: Is the Iranian Regime About to Collapse? Axios: Trump says U.S. is ready to help Iranians get freedom AP News: Suspect arrested on suspicion of arson after a fire damages a historic Mississippi synagogue NYT: An Interview With Donald Trump AP News: Reference to Trump's impeachments is removed from the display of his Smithsonian photo portrait NBC News: New cellphone video shows victim interacting with ICE officer moments before fatal shooting in Minneapolis NYT: ‘Hundreds More' Federal Agents to be Deployed to Minneapolis After ICE Shooting USA Today: Immigration enforcement ramp-up has only just begun, VP Vance promises WAPo: Inside ICE's social media machine creating viral arrest videos Politico: ‘Uninvestable': Trump pitch to oil execs yields no promises Axios: Trump declares national emergency to shield Venezuelan oil cash Texas Tribune: Texas hands over complete list of registered voters to Trump administration Politico: Judge blocks Trump's $10B welfare fund freeze Seattle Times: Judges block Trump plan to cut research money, including $120M for WA AP News: Trump brushes off early posting of confidential jobs figures Morning Announcements is produced by Sami Sage and edited by Grace Hernandez-Johnson Learn more about your ad choices. Visit megaphone.fm/adchoices

Obsessive-Compulsive Disorder (OCD) is common, disabling and frequently misunderstood in clinical practice. In this episode of Practical for Your Practice, hosts Dr. Jenna Ermold and Kevin Holloway are joined by Dr. Elizabeth McIngvale and Dr. Lauren Wadsworth, two nationally recognized leaders in OCD treatment and training, for a deep dive into Exposure and Response Prevention (ERP), the gold-standard treatment for OCD.Together, they unpack why OCD is so often misdiagnosed, mistreated, or unintentionally reinforced, even by well-intentioned clinicians, and how ERP works to interrupt the obsession–compulsion cycle by targeting avoidance, ritualizing, and intolerance of uncertainty.Be sure to listen in and remember, we want to hear from you! Have thoughts about this episode? A “clinical sin” you've encountered? Ideas for future topics or guests?Leave us a voicemail via SpeakPipe https://www.speakpipe.com/cdpp4p Or send us an email cdp-podcast-ggg@usuhs.edu . We love hearing from our listeners. As always, until next time, stay curious, and mind your EBPs.Elizabeth McIngvale, Ph.D., LCSW, is the Director of the OCD Institute of Texas, Co-Founder of MHNTI, and faculty at Baylor College of Medicine. A renowned OCD expert, she has published 35+ peer-reviewed works and delivered 250+ lectures. She founded the Peace of Mind Foundation and OCDChallenge.org, now part of the IOCDF, where she serves as a Board Member and former national spokesperson. Diagnosed with OCD at age 12, Dr. McIngvale brings a unique dual perspective as both a clinician and advocate. She has advised NIH and SAMHSA and serves as a faculty instructor for the Behavioral Therapy Training Institute. She remains dedicated to advancing research and expanding access to high-quality care for OCD and anxiety disorders.Dr. Lauren Wadsworth is a board-certified clinical psychologist and Clinical Senior Instructor at the University of Rochester Medical Center. She is the founding director of Genesee Valley Psychology (GVP), providing accessible evidence-based care in Western NY, and Meridian Psychology Practice, serving NY, MA, and GA. As a leader in mental health education, she co-founded the Mental Health National Training Institute (MHNTI) and Twin Stars Diversity Trainers. An expert in diversity and inclusion, she co-authored Did That Just Happen?! Beyond "Diversity" — Creating Sustainable and Inclusive Organizations. Dr. Wadsworth is dedicated to expanding access to evidence-based treatment and fostering inclusive environments through app-based training and organizational consultation.Resources mentioned in this episode: Mental Health Network & Training Institute (MHNTI) Evidence-based training and consultation for OCD and related disorders https://mhnti.comInternational OCD Foundation (IOCDF) Clinician training, resources, and treatment referrals https://iocdf.org Calls-to-action: Subscribe to the Practical for Your Practice PodcastSubmit your comments or questions on our social media pages or via SpeakpipeSubscribe to The Center for Deployment Psychology Monthly Email

Mike Lauer is the former Deputy Director for Extramural Research at the National Institutes of Health. A cardiologist and researcher, he joined the NIH's National Heart, Lung, and Blood Institute in 2007 as the Director of the Division of Prevention and Population Science. From 2015, he oversaw the NIH's $32 billion funding program for external research. Since leaving NIH in 2025, he has become an outspoken advocate for fundamental reform in how the federal government supports biomedical research.We discuss:* Why the NIH used to fund 60% of grant applications — and now funds just 10%* How “soft money” forces researchers to fund their own salaries* How distributing lots of small grants wastes everyone's time* How block grants could fund more breakthrough science* Why researchers don't get their first independent award until their mid-40sThe full transcript for this conversation is at www.statecraft.pub This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.statecraft.pub

In this episode of The Ultimate Assist, John Stockton and Ken Ruettgers are joined by Dr. Nathaniel Mark Mead, a former NIH science editor and published researcher, for a deep dive into myocarditis, immune dysfunction, excess mortality, and scientific censorship in the post-COVID era.Dr. Mead breaks down the data behind mRNA vaccine–associated myocarditis, why many cases were never properly recorded, and how immune dysregulation may be contributing to rising rates of cardiac events, cancer progression, neurological issues, and excess deaths across highly vaccinated countries.The conversation also explores:Why myocarditis is often under-diagnosed and misclassifiedHow vaccine trial design and surveillance systems distorted risk reportingThe concept of “hybrid harms” and cumulative immune damageExcess mortality trends in the U.S., Europe, and AsiaThe suppression and retraction of peer-reviewed researchWhy Dr. Mead continues speaking out despite professional consequencesThis is a data-driven, long-form discussion about science, censorship, and the long-term implications for public health — and why these questions are far from settled.

CNN's John King with the latest national political headlines.Carol Rose, executive director of the ACLU of Mass on oral arguments in Boston over their NIH grants lawsuit. She'll also discuss the anniversary of J6 and the Trump administration's efforts to rewrite history.Lee Pelton of the Boston Foundation discusses the problem of rental deserts in Greater Boston, and the issue of affordability generally.Congressman Jake Auchincloss zooms in to discuss Democrats' response to Trump's actions in Venezuela.Trenni Casey of NBC Sports Boston discusses the Patriots being good on the field, and bad off the field. Plus, a whole new year of Jordon Hudson obsession in sports media.

David Jernigan 0:15Hello! Dr. Deb 0:16Hi there, sorry for all the confusion. David Jernigan 0:19Oh, no worries, you gotta love it, right? Dr. Deb 0:21Oh, I can’t hear you. David Jernigan 0:23No way, let’s see, my mic must be turned off? Dr. Deb 0:27Hang on, I think it’s me. Let’s see…Okay, let’s try now. David Jernigan 0:40Okay, can you hear me? Dr. Deb 0:42Yep, I can hear you now. David Jernigan 0:43Excellent, excellent. And, how are you today? Dr. Deb 0:48I am good, thank you. How about yourself? David Jernigan 0:50I’m good. Well, it’s good to finally meet you and get this thing rolling. Dr. Deb 0:56Yes, yes, I’m so sorry about that. David Jernigan 0:58That’s alright, that’s alright.So… Dr. Deb 1:01Yeah, go ahead. David Jernigan 1:03So, tell me about yourself before we get going. Dr. Deb 1:06Yeah, so I am a nurse practitioner. I’m also a naturopath. I have a practice here in Wisconsin. I’ve been treating Lyme for about 20 years, so I’m really excited to have this conversation and learn what you’re doing, because it’s so exciting and new. David Jernigan 1:21Well, thank you. Dr. Deb 1:22Yeah, so we treat a lot of chronic illness patients, do some anti-aging regenerative things as well, so… David Jernigan 1:30Yeah, I went to your website and saw you guys are killing it, looks like. Dr. Deb 1:35Yeah. David Jernigan 1:35Got a lot of good staff, it looks like. Dr. Deb 1:37Yeah, we’ve got great staff, great patients, busy practice. We have 5 practitioners, so we have about 15,000 patients in our practice right now. David Jernigan 1:46Well, excellent. Yeah. Excellent. Yeah, yeah.So, I’m excited for this discussion. Dr. Deb 1:53Good, me too. So I pre-recorded our intro, so we can just kind of dive right in, and I’ll just ask you to kind of introduce yourself a little bit, tell us a little bit about yourself, and, and then we can just dive right into it. David Jernigan 2:08All right. I’m Dr. David Jernigan, and I own the Biologic Center for Optimum Health in… Franklin, Tennessee, and I’ve been in practice for over 30 years. I shook Willie Bergdurfer’s hand, if anybody knows who that is. It’s kind of infamous now with some of the revelations that have happened about Lyme being a bioweapon and weaponized. But, you know, I’ve been doing this, probably longer than almost anybody that’s still in the business in the natural realm. It chose me. I did not choose Lyme. Matter of fact, there were many times in my career that I was like. You know, cancer’s easier because of the fact that everybody agrees, you know, what we’re dealing with. And in the 90s, it was a whole different reality, where nobody actually understood that you could have Lyme disease and not be coming from New England.You know, so I had actually the first documented case of a Lyme disease, CDC positive.Patient that had never left the state of Kansas before. So they couldn’t say that it wasn’t in Kansas, and so she had actually been, pregnant with… twin boys, and they were born CDC-positive as well, and so it is transmitted across the placenta we know.So, I, you know, the history of how I did all this was, in the 90s, probably 1996, probably, somewhere in there, 97. With this woman, you know, I… if you go into Robin’s pathology books from back then. Which we all used, medical doctors and everybody else studying. you know, there was basically a paragraph about Lyme disease, and on the national board tests, as you recall, it was probably like, what causes, or what is, bullseye rash associated with? And you’d had to guess Lyme disease, of course. Dr. Deb 4:07Female. David Jernigan 4:08But that was, you know, considered to be more a New England illness, and you would never see it anywhere else. But here was this woman. I knew… nothing about Lyme beyond what we had gotten taught in college, which was, like I say, next to nothing. And she would not let me stop feeding me information. I mean, you gotta remember, the internet wasn’t even hardly in existence in those years. I mean, it was brand new. It was supposed to be this information highway, and So I started purchasing, like a lot of doctors do even now, they start purchasing every kind of new supplement that’s supposed to work for bacteria. There was no product in those days that actually was Lyme-specific. I mean, nobody was really dealing with it naturally. It was always a pharmaceutical situation. Dr. Deb 5:04And a very short course at that. David Jernigan 5:06Yeah, 2 weeks of doxy and you’re cured, whether your symptoms are gone or not, which… she’d had the 2 weeks of doxy, and her symptoms and her son’s symptoms were not gone. And so, I absolutely just purchased everything I could find. Nothing would work. I mean, I could name names of products, and you would recognize them, because they’re still out there today. Dr. Deb 5:28Which is. David Jernigan 5:30Kind of a… A sad thing that natural medicine is still riding on these things that have the most marketing. Dr. Deb 5:37As opposed to sometimes the things that actually have the documented research. David Jernigan 5:42Behind it, and I am a doctor of chiropractic medicine, and I specialized all these years in chronic, incurable illnesses of all types. That may sound odd to a lot of people, but doctors of chiropractic medicine are trained just like a GP typically would be. The medical schools, as I understand it, got together, decades ago and said, wow, if all we did was… Crank out general practitioners for the next 10 years, we wouldn’t have still enough general practitioners to supply the demand. Dr. Deb 6:17Right. Everybody in medicine, in medical schools, wanted to be a specialist, because that’s where the money was, and it was… David Jernigan 6:24Easier, kind of, also, to… you know, just focus on one part of the body, and specialize in that. Dr. Deb 6:31Expert in that one area. David Jernigan 6:32So we all now have the same training. We all go through pre-med. We got a bachelor’s degree, I got my bachelor’s degree in nutrition, and through, Park University in Parkville, Missouri. And so, you know, when I ran out of options to purchase, I just used a technology that I developed, which was an advancement upon other technologies, but I called it bioresonance scanning. And I coined the term back in the 90s. It was a way to kind ofKind of like a sensitive test, you know, like you might. Dr. Deb 7:09I wouldn’t. David Jernigan 7:09Of applied kinesiology, then clinical kinesiology, then chiro plus kinesiology, then, you know, you can just keep going with all the advancements that were made. Well, this was an advancement upon those things, so… I developed… I was the first in… in… my known world of doctors to develop a way to detect adjunctively, obviously we can’t say it’s a primary diagnosis. Adjunctively detect the presence of a given specimen. So we could say, thus saith my test. It’s highly likely you have Borrelia burgdurferi. And, but I had to have the specimen on hand to be able to match what I call frequency matching to the specimen. Brand new concept in those days. And so I was able to detect whether or not my treatments were successful or not. This is something even now that’s really difficult for doctors, because antibody tests, even the most advanced ones, it’s still an antibody test. It’s still an immune response to an infection.And accurately, you know, some doctors will slam those tests, saying, well. That doesn’t mean you actually have the infection, that just means your body has seen it before, which is a correct statement, kind of. So being able to detect the presence, and even where in the body these infections are was a way huge advancement in the 90s, for sure it’s kind of funny, I think about a conference I went to, and cuz… I’m kind of jumping ahead. Because I ended up developing my own formula, just for this woman and her children, and it worked. And I was like, wow! Their symptoms were gone, all the blood tests came back negative. In those days, we were using the iGenX. Western blot, eventually. And the, what was called a Lyme urine antigen test. I don’t know if you remember that, because it… Only decades later did I meet, the owner of iGenX, Nick Harris. Dr. Deb 9:17Person. And I was like, whatever happened to the Luwat test? Because I took it off the market after a while. He said, honestly, we lost the antigen and couldn’t find it again. Oh, no. David Jernigan 9:27And so… but that was a brilliant test. It was the actual gold standard in those days. Again, the world… it can’t be understated how different the world was in the 90s. Dr. Deb 9:40Yeah. David Jernigan 9:41Towards natural medicine, even. Dr. Deb 9:44Oh, yeah. We think… we think it’s bad now, but, like, when I started, too, I started in the early 2000s, like, we were all hiding under the radar, like, you didn’t market, we would have never been on social media, we didn’t run ads, we didn’t do any. David Jernigan 10:00Right. Dr. Deb 10:01Because the medical boards were coming for us. David Jernigan 10:04Came after me. Dr. Deb 10:05Because I had the word Lime on my page, my website. David Jernigan 10:10You know, not saying that I treat Lyme. Dr. Deb 10:13Hmm? David Jernigan 10:13Yes Dr. Deb 10:15Just talking about mind. David Jernigan 10:16And it’s funny, because, once I had this formula, it was something… and I trained in Germany, in anthroposophical medicine, and they’ve been trained in herbal… making herbal extracts, making homeopathic remedies in the anthroposophical methodology, and I trained with the Hahnemann versions of homeopathy, which is just slightly different. Yeah. And, so I was well-versed with making some of my own formulas by that time. And so, it was really something that I wrote on the bottle, you know, and I had to call it something, so I called it Borreligin, which is still in existence, and it’s still a phenomenal herbal remedy right now. And to my knowledge, it’s the only frequency-matched herbal formula. Maybe still out there. Because unless you knew how to do my testing, the bioresonent scanning, there was no way to actually do frequency matching. Matter of fact, as a really famous herbalist attacked me online, saying, oh, none of these herbs will kill anything. And I’m like, that wasn’t what I was saying. I was saying, back in those days, I was saying, well, if… what would the body need to address these infections?You know, not, like, what’s gonna kill the infections for the body. Dr. Deb 11:38Right. David Jernigan 11:39Right? So it was a phenomenal way, but the LUAT test was amazing because what you’d do is you would give your treatment, like an MD would give an antibiotic for a week, ahead of time. Trying to increase the number of dead spirochetes showing up in your urine one day out of 3 days urine catch. So you’d wake up in the morning, you’d collect your urine 3 days in a row, and any one of those being positive is a positive. But it was a brilliant test because it wasn’t an antibody test. They were literally counting the number of dead pieces of Lyme bacteria in your urine. I mean, it was pretty irrefutable. So I had a grand slam on the… the Western blot on patients, and I’d also have a grand slam on the LUAT, and their medical doctors would say, oh, that doctor in the lab are probably in cahoots change some lab. Dr. Deb 12:38Of course. David Jernigan 12:39That come in. And I still see that today. You know, it’s like, oh my gosh, the better the tests are getting. There’s still a bias if you do your own research. Well, if you happen to be a doctor who loves research. And you’re a clinician, so you actually treat patients who’s gonna write the research study? Well, of course, the doctor who did the study, well, he’s biased, and I’m like, I still can’t influence lab tests. Well, lab tests aren’t everything. People scream over the internet at me. It’s like, well, a negative lab test doesn’t mean anything. I was like… I get that with the old Western blot testing. Dr. Deb 13:16Right. David Jernigan 13:16The more sensitive tests, which are very close to 100%, Sensitivity, and 100% specificity. So, meaning, like, they can… if you have the infection, they’re gonna find it. Dr. Deb 13:30They’ll find it, yeah. David Jernigan 13:31And if they… if you have the infection, they’re going to be able to tell you exactly 100% correctly what kind of infection it is. Back in those days, you couldn’t, you could just count the dead pieces, which was… Dr. Deb 13:43Yeah. David Jernigan 13:43Significant, but It’s funny, because when medicine does that, you know, mainstream medicine that’s backed by all the nice foundations who donate millions of dollars towards the research. Their negative tests are significant, but if you fund your own, Yours isn’t that significant. Dr. Deb 14:04Right, or what if we call something a seronegative autoimmune disease, like lupus or rheumatoid arthritis, because none of the tests are positive, but you have all the symptoms. Here, let me give you this $100,000 a year drug. David Jernigan 14:19Yeah. Dr. Deb 14:19And instead of looking for what might actually be causing the symptoms. That’s all okay, but what we do is not okay. David Jernigan 14:27Right. Yeah, it’s a double standard, and it’s getting better. I want to do… tell the world it is getting better. Some of the dinosaurs are retiring. Dr. Deb 14:36No. David Jernigan 14:37Way for people who are… Are more open-minded to new ideas. But, getting back to that woman, she… that formula that I made just for her and her son, I… She went online. Dr. Deb 14:54Which, I had never been on a news group. David Jernigan 14:58Not even sure I knew what one was, you know? Imagine, I’m kind of that dinosaur that… Cell phones were, like, these really big things with a big antenna sticking out of it, and… Dr. Deb 15:09Nope. David Jernigan 15:10So I thought I was pretty hot stuff, just that I actually had a computer software program that was running my front desk. And even then, it was an Apple IIe computer. Dr. Deb 15:21Right. David Jernigan 15:22Probably be pretty valuable right now if I’d kept it, but… Dr. Deb 15:25Mmm… David Jernigan 15:26It being an antique. But, suddenly people were calling my clinic, because the lady with the twin boys that was well was telling people on these research, I mean, these Lyme disease forums and boards online. And, I started going, oh my gosh, you know, as a doctor, it’s one thing to treat a person in your clinic, it’s a different thing to have your clinic name on the label. Like, we all do, Even now, and you’re supposed to write everything that’s on the label, and… all these guidelines, and I’m like, wow, I need to split this off. I mean, I def… I definitely want to help people, and this is… I was pretty excited about the results we were getting. Pre-treat… Pre-treatment and post-treatment. And, so… that’s where I developed, my nutraceutical business in the 90s called Journey Good Nutraceuticals. My advice to anybody thinking about doing the same thing, don’t put your last name on it. Dr. Deb 16:25– David Jernigan 16:25You know, because anytime negative anything comes out, there goes the Jernigan name, you know, the herbal, you know, there’s just all these, and especially nowadays, with all the bots that are just designed to slam natural medicine. Dr. Deb 16:38Yeah. David Jernigan 16:39And that is out there in a… and just ugly people. Dr. Deb 16:42Or should we just say, people with a different opinion? How’s that? David Jernigan 16:46Yeah. That are being less than supportive. Dr. Deb 16:49But. David Jernigan 16:51It was amazing, because by 1999, I presented my research, my first research, I’d never done research. This is what I would… I would say to a lot of people who go, my doctor did… I don’t know, my doctor doesn’t know what you’re doing, my doctor… I was like going, you know, most doctors don’t do research. They don’t publish anything. Their opinion is their opinion, but they don’t back it up in peer review, right? And so that’s what I always tried to do, was back it up in peer review and publish. And so, in 1999, I presented at the International Tick-Borne Diseases Conference in New York City. I’m telling you, it was like the country boy going to the city, you know, I got my… I got my suit on, and I looked all right, and my booth was wonderful, and all these different things, and it was just a big wake-up call.Because what we had demonstrated… let’s get back to the… and this was what I demonstrated with that first study. was that… A positive LUAC test, that Lyme urine antigen test for my Gen X, was a score of 32. Meaning, one of those 3 mornings urine had 32 pieces in the amount of urine they checked of deadline bacteria spirochetes. Okay? Okay. With antibiotic challenges, a highly positive was a score of 45. Dr. Deb 18:19Wow when I would give one dropper 3 times a day for a week. David Jernigan 18:24Ahead of time, and then do the person’s LUAT test, We were getting scores 100, 200… And at that point, we only had a couple, but we had a couple that were greater than 400. Yeah, dead pieces, where the lab just quits counting. They just said, somewhere over 400, right? Dr. Deb 18:45Yeah. David Jernigan 18:46Which, when the medical system at the conference, you know, I was the only natural doctor in the world that was… had any kind of proof of anything naturally that could outperform antibiotics. Can you imagine? Dr. Deb 18:59Yeah. And… David Jernigan 19:01They were just, oh my gosh, incredulous. They’re like, I’ve given the most… one guy came up to me, and to my face, and he goes, I’ve given the most aggressive antibiotic protocols And I’ve only seen one patient over 100. I was like, that makes this pretty significant, doesn’t it? But, it didn’t just, like, make us take off, because guess what? In Lyme world, if a pharmaceutical antibiotic made you feel horrible. That meant it was working. Dr. Deb 19:28That’s right. We used to, back in the day, if you didn’t herx. And had that horrible die-off reaction, for those of you who don’t know what a herx is, but if we didn’t make you herx, we weren’t doing our job right. David Jernigan 19:40You’re looking for your patients to feel horrible, and sometimes to the level of committing suicide. Dr. Deb 19:46Yes. David Jernigan 19:47So bad. Dr. Deb 19:48Yes. David Jernigan 19:49And I was the first doctor, I think, in the world to start screaming and hollering and saying, stop using the worsening of your patient’s symptoms as a guide to good treatment, because they’re… I wasn’t seeing it with my formulas. Because I was doing a comprehensive program of care. I think I was also one of the first doctors to say, we need to detoxify these people as we’re doing this. And you would sit there and say, well, sure you were. I was like, well, remember, there wasn’t a lot of communication. There wasn’t anybody on the internet saying, do this, do that. And, It was, it was interesting in those days. It was, how do you… How do you help the world heal from these things? That they don’t know they have. So later, I actually had a beautiful booth at a health… a big health expo in Texas, I remember, and I was like, you know, you spend a lot of money on the booth, and… Dr. Deb 20:43Yup. David Jernigan 20:43And you’re thinking about it because you’re funding the whole thing, you say, wow, if I only sell one case, I’ll at least cover my cost. Dr. Deb 20:51Yep. Yeah, you’re great. David Jernigan 20:52And I had this beautiful banner of, like, a blown-up tick’s mouth under microscope. You know those beautiful pictures of, like, all the barbs sticking out, and how they anchor themselves in your skin, and… And, thousand people walking by my booth, and they’re just like, keep walking, because they didn’t know they had Lyme. There was, like, and they had MS, maybe, but they don’t have Lyme, and so they just would keep walking. Nobody even knew. Why would I go to a conference in Texas? And I’m trying to say, no, guys, it’s everywhere. Dr. Deb 21:24Yeah. David Jernigan 21:24And… and everybody, you know, yes, you probably have this, you know, kind of thing. If you’re… if you… are chronically ill, almost, of any kind of way. You know, kind of trying to tell people this was… Again, in Robin’s pathology textbooks, one of the few things that it did tell you about Lyme was that it was called the Great… the New Great Imitator. Because it would imitate up to 200 or more different illnesses. So, it’s been an interesting journey, of… educating people, writing articles, but it was interesting, the lady who I first fixed, Laboratory verified, everything like that, symptoms went away, all that kind of fun stuff. Her children were fine, they’ve been fine for years now. When she went on the newsboards in the Lyme disease support groups, It created a war. Oh my goodness, it was like, how dare you? And, say that something natural might actually help, right? Dr. Deb 22:30Right, exactly. David Jernigan 22:32And, I even had… A… one of those first calls to… with a marketing company at one point, way a long time ago. And the lady got on the phone, the owner of the marketing company goes, I would have blood on my hands if I actually took your clinic on. Yeah, you can’t treat Lyme disease, and… Even the big, big associations that are out there are still largely that way. I mean, they’re getting better, but it’s just like… you know, a lot of the times, it’s herbs are good. Herbs will help. Good, you know, but they’re safe. So, it’s still a challenge to… to… present in mainstream Lyme communities, even. Because there’s this… Fear of doing anything outside of antibiotics. Dr. Deb 23:32Yeah, so let me ask you this. From your perspective. Why do you think so many chronic infections exist these days, like Lyme and the co-infections, Babesia, Bartonella, mold illness? And we talked a little bit about herbs and why they, antibiotics and things like that fail, but let’s talk a little bit about that. David Jernigan 23:53So, it’s fascinating. When I trained in Germany, they said that we, as humanity, has moved away from what they called the inflammatory diseases. You know, in the old days, it was. Lots of high fevers, purulent, pus-generating bacterial infections. And I said, as a society, we have… Dr. Deb 24:14Have shifted from those to what they call cold sclerotic diseases, which are your… David Jernigan 24:21Cancers, your diabetes, your atherosclerosis, your… and they said, we’re starting to see what used to only be geriatric diseases in our children. That’s how bad it’s gotten. We have suppressed fevers, we don’t… we don’t respect the wisdom of the human body. So, you know, the doctors say, step aside, body, I will fix this infection for you with this antibiotic. And so, what we’ve done with the, overuse of antibiotics, and this isn’t me just talking from a natural perspective, this is… Right, it’s everybody around the world is acknowledging. I’ll show you… I could show you a, a presentation, if we can do a screen-sharing situation. Yeah. About the antibiotic situation in the world, because it’s really concerning. But what I would say, and kind of like an advancement forward, is we are seeing mutated bacteria. You know, they talked about… do you remember when they found the Iceman, you know, the… You know, the prehistoric guy that’s… In the eyes, and he had Lyme bacteria. I was like, he had spirochetes, maybe. Dr. Deb 25:33Yeah. David Jernigan 25:33That isn’t a modified, mutated version. That’s just maybe the… Lyme… you know, Borrelia… call it Borrelia something, you know, it’s a spirochete, but what we’re dealing with today. Even under strep or staph, as you know, you know, Pseudomonas aeruginosa, you name it, whatever kind of infection a person has is not the same bacteria that your grandparents dealt with. Dr. Deb 26:01That’s right. David Jernigan 26:32It’s a much mutated, stronger, more resistant to treatment type of thing. So, I think that’s one reason. I think the, It’s great that we’re seeing, you know, Secretary Robert F. Kennedy Jr. bringing awareness to things that Like it or not, yeah, seed oils do create inflammation, and everyone in the natural realm, as you know. Has been trying to say this for probably how long? Dr. Deb 26:35Yeah, 25, 30 years. 20 years each. David Jernigan 26:48Yes. You know, thank goodness for people like Sally Fallon and her beautiful book, Nourishing Traditions, that started you know, Dr. Bernard Jensen’s books way back in the day, Dr. Christopher’s books way back in the day. Dr. Deb 26:48Damn. David Jernigan 26:49You know, all of them were way ahead of their time, saying, by the way, your margarine is only missing one ingredient from being axle grease. Dr. Deb 26:58Yeah. David Jernigan 26:58I think that was Dr. Jensen saying that at one point, probably 50, 60 years ago, I don’t know. Dr. Deb 27:03Yep. David Jernigan 27:04So, we’ve created this monster. We, we live in a very controlled environment, you know, of 72, 74 degrees at all times, we don’t sweat, we don’t have to work that hard, typically. You know, most of us aren’t out there like our ancestors were, so that’s making us more and more… Move towards the cold sclerotic diseases, of which even Lyme disease is, you know, which… Yes, it has inflammation, yes, but as a presentation, it’s very often associated with some of these Cold sclerotic diseases of mankind that we see now. Dr. Deb 27:46You have it. David Jernigan 27:47Yeah. Dr. Deb 27:48So, tell me, what is phage therapy? David Jernigan 27:52Well, may I show you a cool video? Dr. Deb 27:55Yeah, I’d love that. David Jernigan 27:56I did not make this video, this is just one of my favorites, because it’s from the National Institute of Health. Let’s see if I can just… Click the share screen thing. And get that to pop up. That’s not what I’m looking for, but it’s gonna be soon. Let’s go here… Alright, can you see that? Dr. Deb 28:18Yeah. David Jernigan 28:19Okay. Modern medicine faces a serious problem. Thanks in part to overuse and misuse of antibiotics, many bacteria are gaining resistance to our most common cures. Researchers are probing possible alternatives to antibiotics, including phages. So, bacteriophages, or we like to call them phages for short, are naturally occurring viruses that infect and kill bacteria. The basic structure consists of a head, a sheath, and tail fibers. The tail fibers are what mediate attachment to the bacterial cell. The DNA stored in the head will then travel down the sheath and be injected inside the cell. Once inside the cell, the phage will hijack the cellular machinery to make many copies of itself. Lastly, the newly assembled phages burst forth from the bacterium, which resets their phage life cycle and kills the bacterium in the process. Someday, healthcare providers may be able to treat MRSA and other stubborn bacterial infections using a mixture of phages, or a phage cocktail process would be first to identify what the pathogen is that’s causing the infection. So the bacterium is isolated and is characterized. And then there’s a need to select a phage in a process known as screening of phage that are either present in a repository or in a so-called phage library. That allows for many of the phages to be evaluated for effectiveness against that isolated I don’t know, bacterium. Phages were first discovered over 100 years ago by a French-Canadian named Felice Derrell. They initially gained popularity in Eastern Europe, however, Western countries largely abandoned phages in favor of antibiotics, which were better understood and easier to produce in large quantities. Now, with bacteria like these gaining resistance to antibiotics, phage research is gaining momentum in the United States once again. NIAID recently partnered with other government agencies to host a phage workshop, where researchers from NIH, FTA, the commercial sector, and academia gathered to discuss recent progress. NIH… So… That is… That is what phage therapy in… is. in what I call conventional phage. Let’s see, how do I get out of the share screen? Hope you already don’t see it. Dr. Deb 30:58Yep, at the top, there should just be a button. David Jernigan 31:00I don’t. Dr. Deb 31:00Stop sharing, yeah. David Jernigan 31:01So… Conventional phage therapy, as you just saw, is a lot like what it is that we’re doing, only the difference is they’re taking wild phages from the environment. They’re finding phages anywhere there’s, like, a lot of bacteria. And then they isolate those phages, and like he said, the gentleman at the very end said we put them in a library, and so there are banks of phages that they can actually now use, and One of the largest banks that I know of has about 700 different bacteriophages, or phages. In their bank that they can pull from. Dr. Deb 31:43Wow. Do you want to take a guess? David Jernigan 31:46How many bacteriophages they’ve identified are in the human gut, on average? Dr. Deb 31:52Oh my god, there’s gotta be more… David Jernigan 31:53Kinds, different kinds of phages, how many? Dr. Deb 31:56There’s gotta be millions. David Jernigan 31:57Well… In population, there’s… humongous numbers, numbers probably well beyond the trillions, okay? Hundreds of trillions, quadrillions, maybe, even. But in the gut, a recent peer-reviewed journal article said that there were 32,242 different types of bacteriophages that live naturally in your intestines, your gut. Dr. Deb 32:25Boom. David Jernigan 32:2632,000. Okay, so… If you read any article on phage therapy that’s in peer review, almost every single one in the very first paragraph, they use the same sentence. They go, Phages are ubiquitous in nature. They’re ubiquitous in nature. So my brain, when I find… when all this finally clicked together, and when we clicked together 5 years into my research, I could not get it to work for 5 years. I just kept going. But that sentence really got me going. I was, like, going, you know. If you look at what ubiquitous means, it says if Phages were the size of grains of sand. Like sand on the beach. They would completely cover the earth and be 50 miles deep. How crazy is that? Dr. Deb 33:24Wow. David Jernigan 33:25That’s how many phages are on the planet. There’s so many… they outnumber every species collectively on the planet. So, it’s an impossibility in my mind. I went, huh, it’s an impossibility that… You catching a, a sterile Bacteria, it’s almost an impossibility. Since the beginning of time, phages have been needing to use a reproductive host. And it’s very specific, so every kind of bacteria has its own kind of phage it uses as a reproductive host. Because phages are… and this is a clarification I want to make for people. just like in the old days, we were talking about the 90s, I talked to a veterinarian that had gotten in trouble with the veterinary board in her state. Dr. Deb 34:14Back in the old days. David Jernigan 34:16Because she gave dogs probiotics. And the board thought she was giving the dogs an infection so that she could treat them and make money off of the subsequent infection. Dr. Deb 34:28Oh my god. David Jernigan 34:29Nobody actually had heard of good, friendly bacteria in the veterinary world, I guess she said she had gotten in trouble, and she had to defend herself, that, no, I’m giving friendly, benevolent, beneficial bacteria. Okay, to these animals, and getting good results.So, phages… Are friendly, benevolent, beneficial viruses. That live in your body, but they only will infect a certain type of bacteria. So… What that means is if you have staff.Aureus, you know, Staphylococcus aureus bacteria. That bacteria has its own kind of phage that infects it called a staph aureus phage. E. coli has an E. coli phage. Each type of E. coli has its own phage, so Borrelia burgdurferi has its own Borrelia burgdurferi type of phage, whereas Borrelia miyamotoi alright? Or any of the other Borrelia species, or the Bartonella species, or the… you just keep going, and Moses has its own type of phage that only will infect that type of bacteria. So that’s… You know, when you realize, wow, why are we going to the environment Was my thought. Dr. Deb 35:54Yeah. David Jernigan 34:55Trying to find wild phages and put them into your body, and hopefully they go and do what you want them to do. What if we could trigger the phages themselves that live in your body to, instead of just farming that bacteria that it uses as a host, because what I mean by farming is the phages will only kill 40% of that population of bacteria a day. Dr. Deb 36:20Wow. David Jernigan 36:20And then they send out a signal to all the other phages saying, stop killing! Dr. Deb 36:24It’s like. David Jernigan 36:2560% of the bacteria population left to be breeding stock. It’s kind of like the farmer, the rancher, who… he doesn’t send his whole herd to the butcher. Dr. Deb 36:35Right. David Jernigan 36:36Just to, you know, he keeps his breeding stock. He sends the rest, right? So, the phages will kill 40% of the population every day, just in their reproduction process. Because once there’s so many, as you saw in the video, once the phage lands on top of the bacteria, injects its genetic material into the bacteria, that bacteria genetic engine starts cranking out up to 5,200 phages per bacteria. Dr. Deb 37:06I don’t know who counted all those… David Jernigan 37:08Inside of a bacteria, but some scientists peer-reviewed it and put it out there. that ruptures, and it literally looks like a grenade goes off inside of the bacteria. I wish I’d remembered to bring that video of a phage killing a bacteria, but it just goes, oof. And it’s just a cloud of dust. So, you’re breaking apart a lot of those different toxins and things. So… That’s… That was the impetus to me creating what I did. That and the fact that I looked it up, and I found out that phages will sometimes go… Crazy. I don’t know how to say it. Wiping out 100% of their host. And it could be a trigger, like change in the body’s pH levels, it could be electromagnetically done, you know, like, there’s been documentation of… I think it was, 50 Hz, electricity. Triggering one kind of phage to go… Crazy and annihilate its host population. There’s other ways, but I was, like, going, none of those fit me, you know? It’s not like I’m gonna shock somebody with a… Jumper cable or something to try to get phages to… to do that kind of thing. But the fact that it could be done, they can be triggered, they can switch and suddenly go crazy against their population. But what happens when they kill 100% of their host? The phages themselves die within 4 days. Dr. Deb 38:45Hmm. Because they can’t keep reproducing. David Jernigan 38:47There’s nothing to reproduce them, yeah. Dr. Deb 38:49Yeah. Especially… unless they’re a polyvalent phage, that means a phage that can segue and use. David Jernigan 38:54One or two other kinds of bacteria. To, as a reproductive host. But a lot of phages, if not the majority, are monovalent, which means they have one host that they like to use. And so… Borrelia, so… my study that I ended up doing, and I published the results in 2021, And it’s a small study, but it’s right in there at the high end, believe it or not, of phage research. Most phage research is less than 30 people. In the study. But, we did 26 people.And after one month of doing the phage induction that I invented, which only… Appears to only, induce or stimulate the types of phages that will do the job in your body. I don’t care what kind of phage it is. I don’t care if it’s a Borrelia phage, it may be a polyvalent phage that normally doesn’t use the Borrelia burgdurferi as its number one. Host, but it can. To go and kill that infection. And the fascinating thing is, there was a brand new test that came out at the same time I came out with the idea, literally the same weekend they presented. Dr. Deb 40:1511. David Jernigan 40:15ILADS conference in Boston in 2019. It was called the Felix Borrelia phage Test. So the Felix Borrelia phage test. Because Borrelia are often intracellular, right, they’re buried down in the tissue, they’re not often in the blood that much. And therefore, doing a blood test isn’t really that accurate. But you remember how there’s, like, potentially as many as 5,200 phages of that type erupt from each bacteria when it breaks apart. It’s way easier to detect those phages, because they’re now circulating, those 52, as you saw in the video. 5,200 different phages are now seeking out another Borrelia that they can infect. And so, while they’re out in circulation, that’s easy to find in the bloodstream. So, 77% of the people, so 20 out of 26, were tested after a 2-week period. After only a 4-day round of treatment. Because according to my testing, remember, I can actually test adjunctively to see if I can find any signatures for those kinds of bacteria. And I couldn’t after 4 days, so we discontinued treatment and waited Beyond the 4 days that would allow the phages themselves to die, so we waited about a week and a half.And redid the test. And 77%, so that 20 out of 26 of the people, were completely negative. Dr. Deb 41:50Wow. David Jernigan 41:52Which, you go, well, it’s just a blood test. Well, no, we actually had people that were getting better, like, they’d never gotten better before. We had one woman who was wheelchair-bound, and in two weeks was able to walk, and even ultimately wanted to work for my clinic. I’m just, like, going… Dr. Deb 42:07I didn’t want to write about all that. I wanted to write about the phages. I was like… David Jernigan 42:12article, I probably should have put some of those stories, because, Critics would say, well, you got rid of the infection, maybe, but… Did you fix the Lyme disease? Well, that’s… there’s two factors here that every doctor needs to understand. There’s the infection in chronic illness, there’s the infection, and then there’s the damage that’s been done. Because sometimes I have these people that would come in and say, well, Dr. Jernigan, it didn’t work for me, I’m still in the wheelchair. And I’m like, no, it worked. Repeat lab test over months says it’s gone, it’s gone, it’s gone. It’s like, we would follow, and 88% of the people we followed long-term were still negative, which is amazing to me. Dr. Deb 42:56And then they have to repair the damage. David Jernigan 42:59It’s the damages why you still have your symptoms. And that’s where the doctor has to get busy, right? Dr. Deb 43:06Right David Jernigan 43:06They were told erroneously by their doctor that originally treated them that they’d be well, they’d get out of the wheelchair, if he could actually kill all these infections. Dr. Deb 43:15It’s not true. David Jernigan 43:16Unless it’s caught early. So I love the analogy, and I’ve said it a thousand times.that Lyme disease and chronic infections are much like having termites in the wood of your house. If you find the termites early, then yeah, killing the infection, life goes back to normal, the storm comes and your house doesn’t fall down. But if it’s 20 years later. Killing the termites is still a grand idea. Right. But you have the damage in the wood that needs to be repaired as well. All the systems… when I talk about damage to the wood, I mean, like. All the bioregulatory aspects of the body, how it regulates itself, all the biochemical pathways, the metabolic pathways we all know about, getting the toxins that have been lodged in there for many years, stopping the inflammatory things that have been running crazy. Dealing with all those cytokines that are just running rampant through the body, creating this whole MCAS situation. Which are largely… Dr. Deb 44:21Coming from your body’s own immune cells called macrophages, which are not even… David Jernigan 44:26It’s not… a virus at all, it’s part of the immune system, it’s like a Pac-Man, and research shows that especially in spirochetes. There is no toxin. Now, I wrote 4 books. I think I wrote the very first book on the natural treatment of people with Lyme disease back in the 90s. Why did I write that? Not because I wanted to be famous, it’s a tiny book, actually, the first one was.I was just trying to help people get out of this idea that you will be well when you kill all the bugs. I was saying, it’s… you need to be doing this. If you can’t come to my clinic, at least do this. Try to find somebody that will do this for you. And that ultimately led to a bigger book.as I kept learning more, and I was like, going, well, okay, now at least do this amount of stuff. And you need to make sure your doctor is handling this, this, this, and this. And so, the third book was, like, 500 and something pages long. And then the fourth book was 500 and something pages long, and now they’re all obsolete with the whole phage thing, because this just rewrites everything. Dr. Deb 45:34Yeah. David Jernigan 45:34It’s pretty fascinating. Dr. Deb 45:37Do you think the war on bugs, mentality created more chronic illness than it solved? David Jernigan 45:44Because of the tools that doctors had to use, yes. We’re a minority, we’re still a minority, you and I. Dr. Deb 45:54Yep. Our doctoring… David Jernigan 45:56Methods I never had, and you’d never… maybe you did, but I’d never had the ability to grab a prescription pad and write out a prescription. I had to figure out, how do I get… and this was… and still my guiding thing, is like, how do I identify, number one, everything that can be found that’s gone wrong in the human body. And what do I need to provide that body? Like, the body is the carpenter. That has to do the repair, has to regenerate, has to do everything, has to get… everything fixed right? We can’t fix anything. If you have a paper cut, there isn’t a doctor on the planet that can make that go away. Dr. Deb 46:38Right. David Jernigan 46:39Of their own power, much less chronic illnesses. So, all the treatments are like the screws, saws, hammers, you know the carpenter must be able to use. So a lot of the time, doctors are just throwing an entire Home Depot on top of the carpenter. In the form of, like, bags of supplements, you know, hundreds of supplements, I’ve seen patients walk in my door with two suitcasefuls. And they were taking 70 bottles, 65 to 70 bottles of supplements, and I’d be just like, wow, your carpenter who’s been working for 24 hours a day, 7 days a week. He’s exhausted. There’s chaos everywhere, you don’t know where to. Dr. Deb 47:22Starting. David Jernigan 47:22He goes, you want me to do what with all this stuff? Dr. Deb 47:25Yep, I’ve seen the same thing. People… thousands, you know, several thousand dollars a month on supplements, and not any better. But they’re afraid to give up their supplements, too, because they don’t want to go backwards, either, and… there’s got to be a better way on both sides, the conventional side and the alternative side, although you and I don’t say it’s alternative, that’s the way medicine should be, but… David Jernigan 47:48Right. Dr. Deb 47:49We have to have a good balance on both sides. David Jernigan 47:52And I will say, too, in defense of doctors using a lot of supplements, I do use a lot of supplements. Dr. Deb 47:57Yeah, I do too. David Jernigan 47:58but I want to synergize what I’m giving the patient so that the carpenter isn’t overwhelmed and can actually get the job done. Like, everything has to work harmoniously together, so it’s not that… It’s not the number of supplements, and why would you need a lot of supplements? Well, because every system in your body is Messed up. My kind of clientele for 30 years. Our clientele, yours and mine. Dr. Deb 48:25Yeah. David Jernigan 48:26They have been sick, For decades, many of them. Dr. Deb 48:31Yeah. David Jernigan 48:31And if they went into a hospital, they honestly need every department. They need endocrinology, they need their kidney doctor, they need their… They’re a cardiologists, they need a neurologist, they need a rheumatologist. I mean, because none of those doctors are gonna deal with everything. They’re just gonna deal with one piece of the puzzle. And if they did get the benefit of all the different departments they need, yeah, they’d go out with a garbage bag full of stuff, too. Dr. Deb 48:57Hey, wood. David Jernigan 48:58Only, they’re not synergized. They don’t work together. You’re creating this chemistry set of who knows how much poison. And I want to tell your listeners, and I mean, you probably say this to your patients as well. There is a law of pharmacy that I learned eons ago, and it applies to natural medicine, too. Dr. Deb 49:21Yep. David Jernigan 49:22But the law says every drug’s primary side effect Is its primary action. So, if you listen to TV, you can see this on commercials. I love… I love listening to these commercials, because I’m like, wow. let’s… let’s… I don’t want to say I’ve named Brandon. I don’t know if that’s…Inappropriate to name a name brand, but let’s just say you have a pharmaceutical that is for sleep. After they show you this beautiful scene of the person restfully sleeping and everything like that, they tell you the truth. It’s like, this may cause sleepiness… I mean, sleeplessness. Dr. Deb 50:04Yeah. David Jernigan 50:04Found insomnia. Dr. Deb 50:06And headaches, and diarrhea. David Jernigan 50:08All the other things, and if it’s an antidepressant, what does the commercial do after it finishes showing you little bunny foo-foo, jumping through a green, happy people? They tell you, this may create depression, severe depression, and suicidal tendencies, which is the ultimate depression. So, I want everyone to understand you need to figure out what your doctor’s tools are that they’re asking you to take, and they’re wanting you to take it forever, generally in mainstream medicine, right? In the hospitals and everything. They don’t say, hey, your heart has this condition, take this medicine for 3 months, after which time you can get off. Dr. Deb 50:48Yep. David Jernigan 50:49not fixing it, right? So… That, on a timeline, there is a point, if it was truly even fixing anything. That you… it’s done what it should do, and you should get off, even if it’s a natural product. It’s just like. Dr. Deb 51:03Right David Jernigan 51:03It’s done what it should do, and you should get off, but instead. you go through the tree… the correction and out the other side, and that’s where it starts manifesting a lot of the same problems that it had. So, anti-inflammatories, painkillers, imagine the number one side effects are pain inflammation. So, the doctor says, well. If you say, hey, I’m having more pain, what does he do? He ups the dosage. And if he… if that doesn’t work, if you’re still in a lot of pain, which he would be, he changes it to a more powerful thing, right? But it starts the cycle all over again. So when you ask me, it’s like, why are we having so much chronic illness? It’s because of the whole philosophy. is the treatment philosophy of mainstream medicine that despises what you and I do. Because we’re… our philosophy from the start is the biggest thing. It’s like… We’re striving for cure. That dirty four-letter word, cure, we’re not even supposed to use it. And yet, if you look it up in Stedman’s Medical Dictionary, it just means a restoration of health. Remission. Everyone’s like, oh, I’m in remission. I’m like, remission is a drug term. It’s a medical term. Again, look it up in a medical dictionary. It is a pharmaceutical term for a temporary pause Or a reduction of your symptom, but because it’s just… symptom suppression, it will come back. It’s… remission is great, I suppose, in… At the end of, like, where you’ve exhausted everything, because I can’t fix everything, I don’t know about you. Dr. Deb 52:41No, I can’t either, yeah. David Jernigan 52:43you know, on my phone consults, I try to always remind people, as much as I get excited about my technologies gosh, I see so much opportunity to fix you. I always try to go, please understand, I’m gonna tell you what most doctors may not tell you on a phone consultation. I can’t fix everything. Dr. Deb 53:03Yeah. David Jernigan 53:03For all of my tricks, I can’t fix everything. Not tricks, but you know, all my technologies, and all my inventions. Phages, too. They are a tool. You know, antibiotics. I think I wrote a blog one time, it should be on my website somewhere, that says, Antibiotics do not… fix… neurological disease, or… I don’t know, something like that. You know, you’re using the wrong tool. I mean, it does what it does. Dr. Deb 53:32Yeah, you’re using a hammer to do what a screwdriver needs to. David Jernigan 53:35Yeah, you know, it’s like it’s… And yet, you can probably tell her… that you’ve had patients, too, that they go, Dr. Jernigan. My throat was so sore, and as soon as I swallowed that antibiotic. I felt better, and I’m, like, going… How long did it take? Oh, it was immediate! I was like, dude, the gel cap didn’t even have time to dissolve, I mean… Dr. Deb 53:58SIBO. David Jernigan 54:00But, it’s not going to repair the tissues that were all raw. kind of stuff. So, I mean, that ulceration of your throat that’s happening, the inflammation, there’s no anti-inflammatory effect of these things. So, I digress a little bit, but phages, too… I wrote an article that’s on the website, that’s setting healthy expectations for phages, because they want… we can see some amazing things happen, things that in my 30 years, I wish I had all my career to do over again, now having this tool. It’s just that much fun. I… when doctors around the country now are starting to use our inducent formulas, there’s, 13 of them now, formulas. For different broad-spectrum illness presentations. I tell them all the same thing, I was like, you are gonna have so much fun. Dr. Deb 54:53That’s exciting. Women. David Jernigan 54:54Winning is fun, you know? I was like. You know, mainstream medicine may never accept this, I don’t know. I feel a real huge burden, though, to do my best to follow a, very scientific methodology. I’ve published as much as I can publish at this time by myself. I never took money from the… the sources that are out there, because what do they do? They always come… money comes with strings. Dr. Deb 55:22Yes, it does. David Jernigan 55:23I don’t trust… I don’t trust… I mean, if you listen to the, roundtable that Our Secretary Robert F. Kennedy Jr. Dr. Deb 55:35Yeah. David Jernigan 55:36On Lyme disease last week the first couple of speakers were, like, pretty legit. I mean, all of them were legit, but I mean, they were, like, senators and congressmen or something like that, I think. And then you have… RFK Jr. himself, who’s legit. Yeah they were fessing up to the fact that, yes, they were suppressing anything to do with Lyme. Dr. Deb 56:00Yeah. David Jernigan 56:00Our… our highest levels of, marbled halls and pillars and… of medicine were doing everything the way I thought they were. They were suppressing me. I was like, how can you ignore the best formulas ever, and still, I think Borreligen, and now, induced native phage therapy are still, I believe, I don’t… I’ve never seen it, I could be wrong. The only natural things that have been documented in a medical methodology. Dr. Deb 56:34Hmm in the natural realm. I mean, all the herbs that we talk about. David Jernigan 56:39You know, there’s one that was really famous for a while, and it said, we gave… so many patients. This product, and other nutritional supplements. And at the end, X number of them were… dramatically better. That’s not research. Dr. Deb 56:57Right. That’s observation. David Jernigan 56:59The trick there was we gave this one thing, and then we gave high-dose proteolytic enzymes, we gave high dose this, we gave high dose that, but at the end of the study, we’re going to point back at the thing we’re trying to sell you as being what did it. Dr. Deb 57:12Which is what we do in all research, pretty much. David Jernigan 57:15Well… Dr. Deb 57:16tried to… David Jernigan 57:17Good guys, I hope. Dr. Deb 57:18Do the way we want, right? In… in conventional… David Jernigan 57:22Yeah. Dr. Deb 57:22Fantastic David Jernigan 57:23Very often, yeah, in conventional medicine, definitely. Yeah. And, it’s kind of scary, isn’t it, how many pharmaceuticals are slamming us with, because they’re… Dr. Deb 57:33Okay. David Jernigan 57:34There’s a new one on TV every day, and there’s. Dr. Deb 57:36Every day, yes. David Jernigan 57:37It’s like, who comes up with these names? They’re just horrible. Dr. Deb 57:40Yeah, you can’t pronounce them. David Jernigan 57:41I want to be a marketing company and come up with some Zimbabwehika, or something that actually they go with, and I’m like, I just made a million bucks coming up with it. I’ll be glad when that’s not on the TV anymore, which… Oh, me too. Me too. Dr. Deb 57:54Dr. Jaredgen, this was really wonderful. What do you want to leave our listeners with? David Jernigan 58:00Well, you know, everyone’s calling for a new treatment. Dr. Deb 58:05Yeah. You bet. David Jernigan 58:08I have done everything I can do to get it out there, scientifically, in peer review, so that if you want to look up my name. Dr. Deb 58:16I published an open access journal so that you didn’t have to buy the articles. Like, PubMed, you have to be a member. If you want to look at a lot of the research, you have to buy the articles. David Jernigan 58:26I’ve done everything open access so that people had access to the information. I honestly created induced native phage therapy to fix my own wife. I mean, I… I was… I used to think I could actually fix almost anything. Gave me enough time. And, I could not fix her. You know, the first 10 years, she was bedridden. Dr. Deb 58:49Wow. David Jernigan 58:50People go, oh, it’s easy for you, Dr. Jernigan, you’re a doctor. Dr. Deb 58:54Oh yeah, right? Yeah. David Jernigan 58:56Oh my gosh, how many tears have been shed, and how much heartache, and how much of this and that. I mean, 90% of our marriage, she was in, bed, just missing Christmas. All the horror stories you hear in the Lime world, that was her, and I could not get her completely well. And, she’s a very discerning woman. I say that in all my podcasts, because it’s. Dr. Deb 59:19Just… David Jernigan 59:16Amazing. It’s like, every husband, I think, should want a wife that’s… Always, right? Not that you surrender your own opinion, but it’s like, it’s… it was literally, I don’t know what, 6 months before the ILADS conference in Boston in 2029… in 2019 that She said, are you going to the ILADS conference this year? And I’m like, I’ve been going for, like, 15, 20 years, however long it’s been going on, and I was like, I’m not gonna go to this one. And, 3 days before the conference, she says, I think you should go. And I go, okay. Like I say, she’s generally right. And that… I bought a Scientific American magazine at the newsstand in the Nashville airport. Started reading a story about phages in that that copped that edition of the Scientific American, and It was a good article, but it wasn’t super meaty, you know. very deep on those, but I just was stimulated. Something about being at elevation. Dr. Deb 1:00:02Yeah. Your own mountains, I don’t know, I get all inspired. David Jernigan 1:00:25And I wrote in the margins and highlighted this and that until it was, like, ultimately, I spent the entire conference hammering this out. And it worked. And it’s been working, it’s just amazing. It’s… We’re over 200 different infections that we’ve… we’ve clinically or laboratory-wise documented. There’s a new test for my GenX called the CEPCR Lyme Panel. like, culture. 64 different types of infections, and I believe right now the latest count is something like 10 for 10 were completely negative. Dr. Deb 1:01:03Wow. David Jernigan 1:01:03These chronically infected people. And so, that hadn’t been published anywhere. So, in my published article, remember I was talking about that 20 out of the 26 were tested as negative for the infection? That doesn’t mean they’re cured, okay? Remember, they’re chronically damaged. That’s how we need to look at it. Dr. Deb 1:01:23funny David Jernigan 1:01:24damaged. You’re not just chronically infected. And, but with 30-day treatment.24 out of the 26 were tested as negative. Dr. Deb Muth 1:01:34That’s amazing. David Jernigan 1:01:35So 92% of the people were negative.Okay? The chances of that happening, when you run it through statistical analysis.The chances… when you compare the results to the sensitivity percentages, you know, the 100% specificity and 92% sensitivity of the…Of the lab testIt’s a 4.5 nonillion to 1 chance that it was a fluke. Isn’t that amazing? Now, nearly… I’m not even sure how many zeros that is, but it’s a lot. Dr. Deb Muth 1:02:08That’s is awesome. David Jernigan 1:02:09Like, if I just said, well, it’s a one in a million chance it was a fluke.Okay.So, lab tests don’t lie. You’re not done, necessarily, just because you got rid of the infections. Now that formula for Lyme has grown to be 90-plusmicrobes targeted in the one formula. So, we figured out we can actually target individually, but collectively, almost like an antibiotic that’s laser-guided to only go after the bad guys that we targeted.So, all the Borrelia types are targeted, all the Babesias, for,the Bartonellas, the anaplasmosis, you name it, mycoplasma types are all targeted in that one formula, because I said.Took my collective 30 years of experience and 15,000 patients.that I would typically see as co-infections and put them into that one formula, so…When we get these tests coming back that are testing for 64, it’s because of that.So, there’s a lot of coolnesses that I could actually keep going and going. Dr. Deb Muth 1:03:15That’s exciting. David Jernigan 1:03:15I love this topic, but I thank you for letting me come on. Dr. Deb Muth 1:03:18Thank you for joining us. How can people find you? David Jernigan 1:03:22Two ways. There’s the Phagen Corp company that is now manufacturing my formulas.That is P-H-A-G-E-N-C-O-R-P dot com. Practitioners can go there, and there’s a practitioner side of the website that’s very beefy with science, and… and all the formulas that were used, what’s inside of all the formulas, meaning what microbes are targeted by each one. Like, there’s a GI formula, there’s a UTI formula, there’s a SIRS formula, there’s a Lyme formula, there’s a central nervous system type infection formula, there’s… And we can keep going, you know, SIBO, SIFO formula, mold formula… I mean, we’ve discovered so many things that I could just keep going for hours, and… Dr. Deb Muth 1:04:05Yeah. David Jernigan 1:04:06About the discoveries, from where it started in its humble beginnings, To now, so… There’s another way, if you wanted to see our clinic website, is Biologics, with an X, so B-I-O-L-O-G-I-X, Center, C-E-N-T-E-R dot com. And, if somebody thinks they want to be a patient and experience this at our clinic, typically we don’t take just Easy stuff. All we see is chronic.Chronic cases from all over the world. Something like 96% of our patients come from other states and countries. And typically, I’ve been close to 90% for my whole career.About 30-something percent come from other countries in that, so… we’ve gotten really good and learned a lot in having to deal with what nobody else knows what to do with. But if you do want to do that, you can contact us. And, if you… If you don’t get the answers from my patient care staff, then I do free consultations. With the people that are thinking about, whether we can help them or not. Dr. Deb Muth 1:05:13Well, that’s excellent. For those of you who are driving or don’t have any way of writing things down, don’t worry about it, we’ve got you. We will have all of his contact information in our show notes, so you will be able to reach out to him. Thank you again for joining me. This has been an amazing conversation. David Jernigan 1:05:30Thank you, I appreciate you having me on. It was a lot of fun. The post Episode 252 – Induced Native Phage Therapy (INPT) & advanced natural therapies first appeared on Let's Talk Wellness Now.

Meet Emily Cadiz — educator, musician, mom of three, and the visionary founder of Prelude Early Learning, home of Finnegan the Dragon.Emily's journey is nothing short of remarkable. After a traumatic brain injury left her needing to relearn how to talk and walk, she found her way back through music and singing. That deeply personal experience became the foundation for Prelude's innovative, music‑based approach to building language and pre‑reading skills in young children.With master's degrees in education, special education, and music, and over 20 years of experience working with children and families, Emily blends research, creativity, and compassion in everything she does. Her blended learning system, developed in partnership with the NIH, has shown extraordinary results—helping children achieve up to 250% gains in early literacy skills in just weeks.Emily's story resonates on so many levels:✨ A survivor who rebuilt her voice through music✨ An educator transforming how children learn language✨ An innovator closing the kindergarten readiness gap for families and classroomsShe's a powerful guest for conversations about parenting, early education, resilience, and the role of technology in children's development. Viewers walk away inspired—and equipped with practical, joyful tools to support children's literacy journeys.

The New Year begins with biotech running along parallel storylines. There's cause for optimism as the industry's financing gears have begun to churn again and innovation remains as strong as it has ever been, while there's cause for concern as the world's most stable, progressive, science-based regulatory system has become unpredictable amid new leadership at HHS, FDA, and NIH. On the first episode of the BioCentury This Week podcast's seventh year, BioCentury's analysts assess the state of play for biotech in the U.S., Europe, and Asia.The discussion ranges from recent changes at NIH to what's next for rare pediatric disease priority review vouchers, and from Europe's opportunity as FDA enters uncertain terrain to Japan's evolving biotech landscape.Early bird rates for BioCentury and BayHelix's fifth East-West Biopharma Summit end Friday. Act now to join investors, dealmakers and innovators in Seoul this March to source innovation from Asia, or accelerate your own pipeline by finding the right Asia partner.View full story: https://www.biocentury.com/article/657978#BiotechOutlook #FDAUncertainty #GlobalBiotech #RarePediatricDiseasePRV #NIHLeadership00:00 - Introduction01:46 - 2026 Outlook03:56 - Policy Landscape11:48 - Priority Review Vouchers15:03 - Global Perspectives16:57 - Spotlight on Japan21:55 - European Biotech OpportunitiesTo submit a question to BioCentury's editors, email the BioCentury This Week team at podcasts@biocentury.com.Reach us by sending a text

Breath to Breath Film that celebrates the contributions by Dr. Michael WelshA Conversation with Dr. Michael Welsh: The Science That is Saving LivesIt's always such a privilege to feature CF icons on the podcast. Over the years, we've been fortunate to host some of the most influential names in cystic fibrosis research, including Dr. Francis Collins, the former director of the NIH and one of the authors of the Human Genome Project, and his longtime friend Dr. Mitch Drumm, who was working on his doctorate when the CF gene was discovered back in 1989.I actually saw Mitch recently at a dinner, and as many of you know, Dr. Collins continues to be a tireless advocate for good science and for sharing its importance with the world.And now, we add another legend to that list: Dr. Michael Welsh from the University of Iowa.Dr. Welsh tells his story beautifully in the University's film Breath by Breath: Living with Cystic Fibrosis. In it, he describes how his curiosity about the CFTR protein led to groundbreaking discoveries that ultimately laid the foundation for CF therapies, the very treatments that have changed (and saved) thousands of lives, including the lives of my daughters.Dr. Welsh's career is extraordinary, spanning decades of research, mentorship, and discovery. He's the Carver Professor of Internal Medicine and Molecular Physiology and Biophysics at the University of Iowa, and from 1989 to 2024, he served as an Investigator with the Howard Hughes Medical Institute. He currently directs both the Pappajohn Biomedical Institute and the Cystic Fibrosis Research Center.We've linked both his full bio and the film in the show notes, and I highly encourage you to check them out. His accolades could fill pages, actually, an entire book! We had so many laughs too in this podcast! So much fun. You'll really enjoy it.Dr. Welsh shared insights not only into his scientific journey, but also the heart behind the work. He recently received the Lasker Award for pioneering CF research that led to life-saving therapies, a recognition that celebrates decades of persistence, curiosity, and collaboration.We discussed so much:How his team began unraveling the mystery of the CFTR protein and what that breakthrough moment felt likeWhat it's like to see patients thriving because of the treatments that grew from that workWhy the University of Iowa decided to produce Breath by Breath, and what the film means to him personallyWhat new treatments and discoveries he's exploring nowHearing Dr. Welsh describe the intersection of science, hope, and humanity is powerful. You can tell that for him, this work isn't just research, it's a mission.As the documentary shows, CF isn't just a disease studied under a microscope. It's a lived experience for patients and families, one that now includes real hope thanks to the breakthroughs made by scientists like Dr. Michael Welsh.Biography:Dr. Michael Welsh is the Carver Professor of Internal Medicine and Molecular Physiology andBiophysics at the University of Iowa. From 1989-2024, he was an Investigator of the HowardHughes Medical Institute. He directs the Pappajohn Biomedical Institute and the Cystic FibrosisResearch Center.Dr. Welsh obtained an MD and completed an internal medicine residency at the University ofIowa. He then trained in pulmonary medicine and research at the University of California, SanFrancisco and physiology at the University of Texas, Houston.Dr. Welsh and his colleagues discovered that the protein affected in cystic fibrosis is an anionchannel, elucidated its functional mechanisms, discovered ways that mutations disrupt function,and showed that mutations can be rescued. This work led directly to development of medicinesthat target CFTR and are highly effective for most cystic fibrosis patients. To understand diseasepathogenesis, he and his collaborators developed cystic fibrosis pigs, the first mammal, otherthan mice, in which a gene was targeted to generate a disease model.His clinical activities focused on pulmonary diseases. He has trained many physicians andscientists and received the Distinguished Mentor Award, University of Iowa Carver College ofMedicine.To watch the film, click here:  https://uihealthcare.org/cystic-fibrosis-research-iowa#documentaryTo learn more about Dr. Welsh: https://internalmedicine.medicine.uiowa.edu/profile/michael-welsh Please like, subscribe, and comment on our podcasts!Please consider making a donation: https://thebonnellfoundation.org/donate/The Bonnell Foundation website:https://thebonnellfoundation.orgEmail us at: thebonnellfoundation@gmail.com Watch our podcasts on YouTube: https://www.youtube.com/@laurabonnell1136/featuredThanks to our sponsors:Vertex: https://www.vrtx.comViatris: https://www.viatris.com/en

Question the science and you're labeled dangerous. Do it anyway — and you end up running the NIH.Dr. Jay Bhattacharya went from being smeared as a “fringe epidemiologist” for opposing COVID lockdowns to leading the National Institutes of Health at a time when trust in science is collapsing. Dr. Bhattacharya addresses scientific dissent, free speech in medicine, the real fallout of lockdowns, chronic disease, environmental health, and whether the NIH can be rebuilt to serve the people — not the institutions.Thank you to our sponsors!ZEBRA: Use code "ALEX" for 10% off any orderCOZY EARTH: Use code "ALEX" for 40% offAGENT NATEUR: Use code "ALEXCLARK" for 15% offJOOVV: Get an exclusive discount on your first red light therapy orderCROWDHEALTH: Use code “CULTURE” to get your first three months for only $99/monthTOOTHPILLOW: Use code "ALEXCLARK" for a FREE video assessmentOur Guest:Dr. Jay BhattacharyaDr. Jay's Links: NIHXINSTAGRAM

The Scott Peterson case has never been short on controversy, but the newest filings from the Los Angeles Innocence Project may be the most explosive revelations yet. In this Hidden Killers investigation, Tony Brueski breaks down two seismic developments that could shake the foundation of one of America's most famous murder convictions. First: the alleged destruction of key evidence. According to internal Modesto Police logs cited in the LA Innocence Project's 600-page petition, detectives met behind closed doors on May 6, 2003, to discuss discovery decisions. By the next day, two major items were reportedly marked for destruction: • The videotaped interrogations of Medina-burglary suspects Steven Todd and Glenn Pierce • The safe stolen from the Medina home, just yards from the Peterson residence Within weeks, the petition claims, both were gone — no copies, no transcripts, no forensic testing. California law is clear: under Trombetta and Youngblood, intentional destruction of potentially exculpatory evidence can constitute a constitutional violation. If these allegations are accurate, the petition argues, this wasn't a mistake. It was a turning point. Then comes the second bombshell: the recantation of the very expert whose testimony jurors described as “the nail in the coffin.” Dr. Terry D'Vor now states that updated NIH and WHO fetal-growth data contradict his 2004 conclusions, showing baby Connor's measurements were consistent with a January death — when Scott Peterson was already under round-the-clock surveillance. If modern science shifts the timeline, the prosecution's central theory may not survive. This episode unpacks the evidence, the science, and the law — and asks whether the case against Scott Peterson is structurally sound… or structurally broken. #ScottPeterson #LaciPeterson #LAInnocenceProject #HiddenKillers #WrongfulConviction #ForensicScience #EvidenceDestruction #TonyBrueski #TrueCrimeAnalysis #JusticeForLaci Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/@hiddenkillerspod Instagram https://www.instagram.com/hiddenkillerspod/ Facebook https://www.facebook.com/hiddenkillerspod/ Tik-Tok https://www.tiktok.com/@hiddenkillerspod X Twitter https://x.com/tonybpod Listen Ad-Free On Apple Podcasts Here: https://podcasts.apple.com/us/podcast/true-crime-today-premium-plus-ad-free-advance-episode/id1705422872

The Scott Peterson case has never been short on controversy, but the newest filings from the Los Angeles Innocence Project may be the most explosive revelations yet. In this Hidden Killers investigation, Tony Brueski breaks down two seismic developments that could shake the foundation of one of America's most famous murder convictions. First: the alleged destruction of key evidence. According to internal Modesto Police logs cited in the LA Innocence Project's 600-page petition, detectives met behind closed doors on May 6, 2003, to discuss discovery decisions. By the next day, two major items were reportedly marked for destruction: • The videotaped interrogations of Medina-burglary suspects Steven Todd and Glenn Pierce • The safe stolen from the Medina home, just yards from the Peterson residence Within weeks, the petition claims, both were gone — no copies, no transcripts, no forensic testing. California law is clear: under Trombetta and Youngblood, intentional destruction of potentially exculpatory evidence can constitute a constitutional violation. If these allegations are accurate, the petition argues, this wasn't a mistake. It was a turning point. Then comes the second bombshell: the recantation of the very expert whose testimony jurors described as “the nail in the coffin.” Dr. Terry D'Vor now states that updated NIH and WHO fetal-growth data contradict his 2004 conclusions, showing baby Connor's measurements were consistent with a January death — when Scott Peterson was already under round-the-clock surveillance. If modern science shifts the timeline, the prosecution's central theory may not survive. This episode unpacks the evidence, the science, and the law — and asks whether the case against Scott Peterson is structurally sound… or structurally broken. #ScottPeterson #LaciPeterson #LAInnocenceProject #HiddenKillers #WrongfulConviction #ForensicScience #EvidenceDestruction #TonyBrueski #TrueCrimeAnalysis #JusticeForLaci Want to comment and watch this podcast as a video? Check out our YouTube Channel. https://www.youtube.com/@hiddenkillerspod Instagram https://www.instagram.com/hiddenkillerspod/ Facebook https://www.facebook.com/hiddenkillerspod/ Tik-Tok https://www.tiktok.com/@hiddenkillerspod X Twitter https://x.com/tonybpod Listen Ad-Free On Apple Podcasts Here: https://podcasts.apple.com/us/podcast/true-crime-today-premium-plus-ad-free-advance-episode/id1705422872

This month, Mary had the opportuinity to spend time with Dr Alexandra Adams. Alex is Director of the Center for American Indian and Rural Health Excellence (CAIRHE), an NIH-funded center focusing on building research partnerships with rural and Native communities and mentoring junior investigators. Her research focus is community-based and participatory. She works in close partnership with Native American communities to understand and solve health challenges using both scientific rigor and crucial community knowledge.Alex has focused her career on the promotion of family and community wellness and healing trauma through community building. Addressing the effects of climate surprises on health has been central to her work. She also uses storytelling, filmmaking, and other strategies to engage communities and support health.In their conversation, Alex and Mary explored her experience at the interface of Western medicine and rural, American Indian and other indigenous communities. Alex described ways for building healing relationships of trust and sharing - acknowledging the deep wisdom of local communities and of ancestral indigenous knowledge. What Alex describes is medicine at its most responsive. Fully honoring the fact that the health of the land is the health of the people and drawing across the arts to practice what is perhaps the greatest of all healing arts, listening.You can learn more about Dr. Alexandra Adams by visiting her personal website and substack, Longing for Belonging. and her substack. Also check the website for the Center for American Indian and Rural Health Excellence (CAIRHE) where you can learn more about Alex's initiatives with that organization. And here's the link to the Turtle Island Tales website and videos Alex described.Through all of her creative endeavors, Alex lives fully in her relatedness with all beings. This is good medical practice, it's good art, and it's solidly consistent with climate repair. Let's all join her.MUSICMystical Flute Music. Music by morel dua from PixabayTabla Flute 102. Music by Johnson Cherian from PixabayAcoustic Guitar and Flute Fairytale. Music by Denis Pavlov from PixabayOriginal theme music, composed and performed by Gary Ferguson.

Shunji Tomatsu, MD, PhD, Professor and Head, Nemours Children's Health, Delaware, USA; Alessandra d'Azzo, PhD, Emerita Faculty, Genetics, St. Jude Children's Research Hospital, Tennessee, USA; Merve Emecen Sanli, MD, Associate Professor, Department of Pediatrics, University of Texas Southwestern Medical Center, Texas, USA; and Ryan Colburn, patient with Pompe disease and president of Odimm Inc, discuss new and emerging gene therapies for lysosomal disorders.This continuing education activity is provided through collaboration between the Lysosomal and Rare Disorders Research and Treatment Center (LDRTC), CheckRare CE, and AffinityCE. This activity provides continuing education credit for physicians, physician assistants, nurses, nurse practitioners, and genetic counselors. A statement of participation is available to other attendees.To obtain CME/CE credit, please visit https://checkrare.com/learning/p-grids2025-session6-current-issues-in-gene-therapies-for-lysosomal-disorders/  Learning ObjectivesDescribe current and emerging gene therapy data in lysosomal disorders and its clinical relevanceDescribe role of patients in gene therapy developmentFacultyShunji Tomatsu, MD, PhD, Professor and Head, Nemours Children's HealthAlessandra d'Azzo, PhD, Emerita Faculty, Genetics, St. Jude Children's Research HospitalMerve Emecen Sanli, MD, Associate Professor, Department of Pediatrics, University of Texas Southwestern Medical CenterRyan Colburn. Odimm, Inc.DisclosuresAffinityCE staff, LDRTC staff, planners, and reviewers, have no relevant financial relationships with ineligible companies to disclose. Faculty disclosures, listed below, will also be disclosed at the beginning of the Program.Shunji Tomatsu, MD, PhD Dr. Tomatsu has received the following grants: Morquio Foundations and families: Scarlett Grifith, Bennett, A Cure for Roberts, and Morquio Conference; MPS Societies: Japanese, National, and Austrian; NIH grants: 1-R01-HD102545, NIH, NICHD, Tomatsu (PI), 1R01HD104814-01A1, NIH, NICHD, Langan, T.J. (PI), Role: Site-PI, R43HD114328-01, NIH, ACOSTA, WALTER (PI), Role: site PI, 1R43AR084638-01, NIH, MOUNZIH, KHALID (PI); Foundation of NIH: FNIH RFP NUMBER: 2022-BGTC-005 Tomatsu (PI). Alessandra d'Azzo, PhDDr. D'Azzo has no relevant financial relationships to disclose.Merve Emecen Sanli, MDDr. Sanli has no relevant financial relationships to disclose.Ryan ColburnMr. Colburn has an advisory, consulting and/or project based relationship or stock holding with: Abeona Therapeutics, Amicus Therapeutics, Astellas Gene Therapies, Avidity Biosciences, Bayer, Catalyst Pharmaceuticals, Denali Therapeutics, M6P Therapeutics, Sangamo Therapeutics, Sanofi, Solid Biosciences.Mitigation of Relevant Financial RelationshipsAffinityCE adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity. Conflicts of interest for presenting faculty with relevant financial interests were resolved through peer review of content by a non-conflicted reviewer.Accreditation and Credit DesignationPhysiciansThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AffinityCE and the LDRTC. AffinityCE is accredited by the ACCME to provide continuing medical education for physicians.AffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Physician AssistantsAffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Physician Assistants should claim only the credit commensurate with the extent of their participation in the activity.NursesAffinityCE is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation (ANCC). This activity provides a maximum of 1 hours of continuing nursing education credit.Nurse PractitionersAffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Nurse practitioners should claim only the credit commensurate with the extent of their participation in the activity.Genetic CounselorsAffinityCE designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credits™. Genetic Counselors should claim only the credit commensurate with the extent of their participation in the activity.Other ProfessionalsAll other health care professionals completing this continuing education activity will be issued a statement of participation indicating the number of hours of continuing education credit. This may be used for professional education CE credit. Please consult your accrediting organization or licensing board for their acceptance of this CE activity. Participation CostsThere is no cost to participate in this activity.CME InquiriesFor all CME policy-related inquiries, please contact us at ce@affinityced.comSend customer support requests to cds_support+ldrtc@affinityced.com

This Day in Legal History: Fundamental Laws of 1906On December 30, 1905, Tsar Nicholas II signed the “Fundamental Laws of 1906,” marking a pivotal moment in the Russian Empire's struggle between autocracy and constitutionalism. This act came in response to the Revolution of 1905, a period of mass unrest fueled by political repression, economic hardship, and a humiliating defeat in the Russo-Japanese War. The October Manifesto, issued two months earlier, had promised the establishment of a legislative Duma and the expansion of civil liberties. However, the Fundamental Laws, signed in December, revealed the Tsar's intention to retain ultimate authority despite these concessions.The document laid out a framework for governance, establishing a bicameral legislature with the Duma as its lower house, but Article 4 made clear that “the All-Russian Emperor possesses the supreme autocratic power.” This meant that, legally, any legislative progress remained subordinate to the Tsar's will. The laws also granted the Tsar control over the military, foreign policy, and the ability to dissolve the Duma at his discretion.While the Fundamental Laws introduced formal legal structures and acknowledged the existence of limited civil rights, they were largely symbolic gestures rather than meaningful reforms. Instead of curbing autocratic rule, the laws codified it, cloaking absolute monarchy in the appearance of legality. This duality deepened public dissatisfaction and political fragmentation.Rather than stabilizing the empire, the signing of the Fundamental Laws sowed further distrust in the regime and highlighted the Tsar's unwillingness to relinquish power. These contradictions contributed to the failure of the Duma system and fueled revolutionary momentum that would ultimately culminate in the revolutions of 1917.The Trump administration reached an agreement to review certain NIH grant applications that had been stalled or rejected amid a broader legal challenge over cuts to diversity-related research funding. The agreement followed a federal court ruling in Boston that found the NIH acted unlawfully when it canceled grants based on their perceived ties to diversity, equity, and inclusion (DEI) initiatives. Though the Supreme Court later paused part of that ruling and shifted some aspects of the litigation to a court specializing in monetary claims, the review process for future NIH funding remained in legal limbo.Under the new agreement, the NIH will re-evaluate previously frozen or withdrawn grant applications, though it is not required to fund any specific proposals. Plaintiffs in the case, including researchers and several Democratic-led states, argued that the impacted studies—focusing on topics like HIV prevention, LGBTQ health, Alzheimer's, and sexual violence—serve vital public health needs.One of the plaintiffs, University of New Mexico postdoctoral researcher Nikki Maphis, said the agreement allows important scientific work to resume after what she described as an “arbitrary and destructive freeze.” The underlying NIH policy change, which cut funding for projects deemed to reflect ideological rather than scientific priorities, remains contested. A prior ruling blocking the policy is still under appeal by the Department of Health and Human Services.Trump administration agrees to review stalled NIH research grants after lawsuit | ReutersThe Trump administration's aggressive defunding of the Consumer Financial Protection Bureau (CFPB) has pushed the agency to the brink of collapse, jeopardizing one of the few federal institutions explicitly designed to protect everyday Americans from financial harm. Created in the aftermath of the 2008 financial crisis, the CFPB has long served as a crucial recourse for people facing predatory lending, credit reporting errors, identity theft, and financial discrimination. The agency has helped return more than $21 billion to consumers since its founding. And yet, under President Trump's second term, it's being systematically dismantled—through funding cuts, legal challenges, and staffing reductions—with the administration openly declaring its intent to shut the agency down.In the absence of the CFPB, those wronged by financial institutions—like Bianca Jones, who battled a credit reporting error that nearly cost her a home, or Morgan Smith, who turned to the agency after being targeted by identity theft—may find themselves with nowhere to turn. The administration claims the CFPB promotes a political agenda, but the result is fewer protections for those already vulnerable. Rules around medical debt, overdraft fees, credit card terms, and mortgage lending have been gutted. Investigations have been shelved. Enforcement is evaporating.Critics argue that other regulators can fill the gap, but the CFPB was created because no one else was doing the job. Without it, financial institutions are more likely to abuse their power with impunity.You should ask yourself: who benefits when a consumer watchdog is taken offline? Because it certainly isn't the teachers, the single parents, the sick, or the struggling borrowers trying to make sense of a system stacked against them. It's the companies who'd rather not answer for what they do in the dark.Trump's funding cuts put America's consumer watchdog on the brink of collapse | ReutersA federal appeals court ruled that it cannot hear Amazon's constitutional challenge to the structure of the National Labor Relations Board (NLRB), deepening a circuit split on the issue and increasing the likelihood of U.S. Supreme Court review. The 9th Circuit Court of Appeals found that Amazon's case stemmed from a labor dispute and was therefore barred by the Norris-LaGuardia Act, which prohibits courts from intervening in active labor disputes. Amazon had filed the lawsuit to halt an NLRB case claiming it was a joint employer of unionized drivers working for a subcontractor and therefore obligated to bargain with their union.Amazon's broader claim—that the NLRB's structure is unconstitutional because its board members and judges are protected from at-will removal—has gained traction elsewhere. The 5th Circuit, in a recent case involving Elon Musk's SpaceX, ruled that such protections are unlawful and allowed a similar challenge to proceed. But the 9th Circuit firmly disagreed, emphasizing that courts should not interfere with labor board proceedings, regardless of the constitutional claims involved.This ruling aligns with a 3rd Circuit decision and stands in direct conflict with the 5th Circuit, setting the stage for a high-stakes resolution by the Supreme Court. Importantly, the 9th Circuit's ruling doesn't completely shut the door on such challenges—employers can still raise constitutional objections in NLRB proceedings and appeal after the fact. But for now, Amazon and other companies must make their case through the channels Congress established for resolving labor disputes.US court says it can't hear Amazon's NLRB challenge, deepening circuit split | ReutersA Utah judge has granted the release of most of the transcript and audio from a closed hearing in the high-profile case involving the fatal shooting of conservative activist Charlie Kirk. The hearing, held in October, addressed courtroom safety measures for the accused, Tyler Robinson, who is charged with aggravated murder and other serious offenses. Prosecutors allege Robinson fired a single fatal shot from a rooftop during a university event where Kirk was speaking, and they intend to seek the death penalty.Judge Tony Graf ruled that only about one page of the 80-page transcript would remain redacted, primarily for safety and security reasons. He also clarified that media organizations do not need special legal status to cover the proceedings, rejecting a request that would have guaranteed them advance notice of any future attempts to close hearings.Graf has already decided that Robinson can appear in civilian clothing but must remain physically restrained in court. However, media outlets are prohibited from photographing or filming his restraints, as defense attorneys argued such images could bias potential jurors. A hearing set for February will address whether cameras will be allowed in the courtroom at all.Kirk's death, which occurred during a campus debate, triggered widespread condemnation of political violence from across the ideological spectrum.Judge grants release of redacted transcript of Charlie Kirk case hearing | ReutersAs 2025 winds down, my Bloomberg column this week is a year-end piece reflecting not just on what was written, but on which ideas still resonate because the problems they address remain unresolved. The lasting relevance of several pieces underscores how little has shifted in tax and policy debates. A July column urging states to break free from federal tax volatility feels even more urgent now, as states still cling to unstable baselines. Early in the year, hopes that efficiency rhetoric (read: DOGE) might close the tax gap faded, with political discomfort around auditing the wealthy preventing any meaningful change. April's look at the step-up in basis revealed how death, not borrowing, remains the biggest capital gains loophole—and one Congress left untouched in the 2025 tax law. A May column on IRS immigration enforcement gains new resonance as the crackdown deepens, pushing some immigrant workers further from voluntary compliance. And October's piece on Pung v. Isabella County remains live, with the Supreme Court set to decide whether fairness in tax foreclosures means market value or simply what the government collects.Each of these columns anticipated weather patterns we're now standing in—proof less of foresight and more of inertia. If 2026 brings more engagement, even without clear solutions, there's hope that next year's retrospective won't feel like a reprint with new dates.Read the 5 Most Relevant Technically Speaking Columns of 2025 This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.minimumcomp.com/subscribe

In this episode of SleepTech Talk, we explore how patient involvement is reshaping the diagnosis and treatment of obstructive sleep apnea (OSA).Our guest, Chris Gouveia, MD, is a sleep apnea surgeon and otolaryngologist with training at NIH, Northwestern, and Stanford, currently practicing at Kaiser Permanente.Dr. Gouveia shares why involving patients more deeply in their diagnosis and therapy leads to better outcomes — and how offering multiple treatment pathways can dramatically improve the patient journey.We also take a forward-looking view at the future of sleep medicine, including how OSA diagnosis and therapy are evolving beyond a one-size-fits-all approach.⭐ In this episode, we discuss:Why patient engagement is critical in sleep apnea careHow shared decision-making improves adherence and outcomesExpanding therapy options beyond traditional CPAPThe role of surgery, technology, and personalized care in OSAWhat the future holds for sleep apnea diagnosis and treatmentDr. Gouveia is also the author of Night Shift, a Substack focused on sleep health and medicine, where he explores clinical insights and evolving trends in sleep care.This episode is essential listening for clinicians, sleep professionals, and patients who want to understand where sleep apnea care is headed next.ABOUT SLEEPTECH TALKSleepTech Talk brings together leaders in sleep medicine, technology, and innovation to explore the tools and trends shaping the future of sleep health.Catch the show on most podcast platforms or on YouTubewww.youtube.com/@sleeptechtalk A huge thanks to our sponsors:Medbridge Healthcare  : For Job Opportunities with MedBridge Healthcare visit: https://medbridgehealthcare.com/careers/Fisher & Paykel Healthcare  Discover how F&P full-face masks have led millions of people to a great night's sleep at https://www.fphcare.com/curiosityhttps://www.fphcare.com/us/homecare/sleep-apnea/React Health  https://www.reacthealth.com/More resources for clinicians can be found at Sleep Review Magazine  https://sleepreviewmag.com/Don't forget to Like, Share, and Comment! Subscribe to SleepTech Talk for more insights into sleep apnea, CPAP therapy, and innovations shaping the future of sleep care.Whether you're a sleep professional or a healthcare innovator, this episode explores the intersection of technology, patient care, and sleep medicine.Learn more about the show at https://www.sleeptechtalk.com/thetechroomCredits:Audio/ Video: Diego R Mannikarote; Music: Pierce G MannikaroteHosts: J. Emerson Kerr, Robert Miller, Gerald George MannikaroteCopyright: ⓒ 2025 SleepTech Talk ProductionsEpisode 114The views and opinions expressed by guests on SleepTech Talk are their own and do not necessarily reflect those of the podcast hosts or SleepTech Talk as a whole. This podcast is intended for educational and informational purposes only and should not be considered medical advice. Listeners are encouraged to consult with a qualified healthcare professional for any medical concerns or questions.Sleep apnea, obstructive sleep apnea, oral sleep appliance, inspire, surgery, sleep surgery, CPAP, AI, Artificial Intelligence

In this episode, Jonathan and Wendy unpack a relentless wave of public-health controversies—from proposed vaccine rollbacks and ethically indefensible clinical trials to political interference at the FDA and NIH. As science takes a back seat to ideology, they explore how misinformation, regulatory capture, and selective ethics threaten public trust, vulnerable populations, and the future of evidence-based medicine.   Connect with us further on https://sciencebasedmedicine.org/author/jonathanhoward/  The Fine Print The content presented in the "We Want Them Infected" Podcast and associated book is intended for informational and educational purposes only.    The views and opinions expressed by the speakers, hosts, and guests on the podcast do not necessarily reflect the views of the creators, producers, or distributors. The information provided in this podcast should not be considered as a substitute for professional medical, scientific, or legal advice. Listeners and readers are encouraged to consult with relevant experts and authorities for specific guidance and information.   The creators of the podcast and book have made reasonable efforts to ensure that the information provided is accurate and up to date. However, as the field of medical science and the understanding of the COVID-19 pandemic continue to evolve, there may be new developments and insights that are not covered in this content.   The creators are not responsible for any errors or omissions in the content or for any actions taken based on the information provided. They disclaim any liability for any loss, injury, or damage incurred by individuals who rely on the content.   Listeners and readers are urged to use their judgment and conduct their own research when interpreting the information presented in the "We Want Them Infected" podcast and book. It is essential to stay informed about the latest updates, guidelines, and recommendations related to COVID-19 and vaccination from reputable sources, such as government health agencies and medical professionals. By accessing and using the content, you acknowledge and accept the terms of this disclaimer.   Please consult with appropriate experts and authorities for specific guidance on matters related to health, science, and the COVID-19 pandemic.  

In this year-end episode of the Animal Wellness Podcast, host Joseph Grove is joined by Animal Wellness Action leaders to reflect on major wins for animals in 2025—and the critical fights ahead in 2026. • Jennifer Skiff, director of international programs, shares progress in the Kangaroos Are Not Shoes campaign, which has pushed major athletic brands away from kangaroo leather, and previews new international work restoring elephant migration corridors in southern Africa. • Don Green, political director, sounds the alarm on the dangerous Save Our Bacon Act, explaining how it would overturn voter-approved animal welfare laws, punish humane farmers, and undermine states' rights. • Kevin Chambers, lead investigator, details undercover investigations exposing cockfighting and dogfighting rings and explains how federal legislation could strengthen enforcement against organized animal cruelty. • Tami Drake, research and regulatory policy director, breaks down the major strides made by the FDA, CDC, and NIH towards more humane testing methods for drug development. The episode closes with Wayne Pacelle, president of Animal Wellness Action, who reflects on a banner year that included historic progress on ending animal testing, eliminating the school milk mandate, and reshaping corporate practices, while outlining the battles still ahead to protect wildlife and enforce new reforms. Helping animals helps us all—and this episode shows how real change happens. Mentioned in the Episode • Follow our Kangaroos Are Not Shoes work—including new publications such as upcoming report on kangaroo meat in the dogfood trade—bookmark this page. • Visit this link to action immediately to help defeat the Save Our Bacon Act. • Here is a video that shows the brutality of cockfighting. In particular, note the harsh treatment of birds who are still alive after the fight is over. (Note: The clip is disturbing to view.) • Care to support the work of Animal Wellness Action with $25 or any other amount? Please go here. The Animal Wellness podcast is produced by Animal Wellness Action and the Center for a Humane Economy. It focuses on improving the lives of animals in the United States and abroad through legislation and by influencing businesses to create a more humane economy. The show is hosted by veteran journalist and animal-advocate Joseph Grove.    www.animalwellnessaction.org www.centerforahumaneeconomy.org   Facebook: https://www.facebook.com/AnimalWellnessAction Facebook: https://www.facebook.com/centerforahumaneeconomy/ Twitter: https://twitter.com/AWAction_News Twitter: https://twitter.com/TheHumaneCenter   Instagram: https://www.instagram.com/animalwellnessaction/ Instagram: https://www.instagram.com/centerforahumaneeconomy/ LinkedIn: https://www.linkedin.com/company/animal-wellness-action/    YouTube: https://www.youtube.com/channel/UCI_6FxM4hD6oS5VSUwsCnNQ 

If you have ADHD or autism, research shows you're at a much higher risk for developing chronic pain — a connection many doctors and patients still don't know about. In this episode of Hyperfocus, we talk with a doctor who's trying to change that.Dr. Michael Lenz, a Wisconsin-based pain specialist, explains what the medical community is discovering about the connection between ADHD, autism, and chronic pain, including conditions like fibromyalgia and migraines. He also shares stories from his practice, including times when treating a patient's ADHD unexpectedly improved their chronic pain symptoms.For more on this topic:  Dr. Lenz's podcast and bookThe Weak Link: Hypotonia in Infancy and Autism Early Identification - PMCADHD-pain: Characteristics of chronic pain and association with muscular dysregulation in adults with ADHDOrder friend of the show Craig Thomas' book NIH study on joint hypermobility For a transcript and more resources, visit Hyperfocus on Understood.org. You can also email us at hyperfocus@understood.org. Understood.org is a nonprofit organization dedicated to empowering people with learning and thinking differences, like ADHD and dyslexia. If you want to help us continue this work, donate at understood.org/give Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen in as we talk with Dr. Kate Creevy about her fascinating and insightful path in veterinary medicine. She shares how decisions she didn't see as impactful at the time played crucial roles in her career development, and the important role of science and research for the future of human and animal kind. Plus, learn how a phone call that started with “I got this guy in genetics” led to her role as Co-Founder and Chief Veterinary Officer with the Dog Aging Project, and her advice to veterinary students and colleagues as a veterinary school professor. This is one of those episodes you will want to listen to, save, and listen to again. As always, we want to hear from YOU. Please share your thoughts by sending an email or joining the conversation.     Photo credit: Texas A&M University College of Veterinary Medicine & Biomedical Sciences photo, Dr Creevy with two Border Collies at different parts of their lifespan journey - Poet at age 3, and Sophie at age 14. GUEST BIO: Kate Creevy, DVM, MS, DACVIM-SAIM Dr. Creevy's educational path includes Georgetown University (BS), the University of Tennessee (DVM), the University of Minnesota (small animal rotating internship) and the University of Georgia (internal medicine residency and MS in Infectious Disease). Along the way she has worked in emergency practice in the Twin Cities and Washington DC, as well as academic emergency practice at UGA, and completed a Cancer Research Training Award Fellowship developing protocols for chimeric bone marrow transplantation in immunodeficient dogs at the NIH's National Cancer Institute. After ten years as a small animal internist on UGA's faculty, she joined the faculty at Texas A&M University's School of Veterinary Medicine where she is now a Professor in Small Animal Internal Medicine.  Dr. Creevy is the Chief Veterinary Officer for the Dog Aging Project, a multicenter, multidisciplinary research collaboration, with over 50,000 dogs enrolled across the US. The long-term goal of the Dog Aging Project is to understand the genetic and environmental determinants of healthy aging in companion dogs. In addition to her work on canine aging, Dr. Creevy's research interests include infectious disease, and the development of lifelong learning skills and critical thinking skills among professional students and early-career veterinarians.     LINKS AND INFORMATION: Dog Aging Project: https://dogagingproject.org/ University of Tennessee, College of Veterinary Medicine: https://vetmed.tennessee.edu/ University of Georgia, College of Veterinary Medicine: https://vet.uga.edu/ Texas A&M College of Veterinary Medicine: https://vetmed.tamu.edu/ One Health: https://www.who.int/health-topics/one-health#tab=tab_1 Zoobiquity book: https://www.zoobiquity.com/ Lessons in Chemistry book: https://www.goodreads.com/book/show/58065033-lessons-in-chemistry   If you like these podcast and want to hear more, please support these efforts through a donation to the VIN Foundation: https://vinfoundation.org/give/ You may learn more about the VIN Foundation, on the website, or join the conversation on Facebook, Instagram, LinkedIn, or signup for the newsletter. If you like this podcast, we would appreciate it if you follow and share. As always, we welcome feedback. If you have an idea for a podcast episode, we'd love to hear it!

2025 was a hard year for science. The Trump administration upended federal funding for all kinds of scientific pursuits, slashing budgets across agencies like NASA, NIH and NOAA. NPR's Rob Stein and Katia Riddle spoke to scientists and officials who worry that those cuts could cause the United States to lose its competitive edge as a global hub for research and innovation, and steer future generations away from careers in science. For sponsor-free episodes of Consider This, sign up for Consider This+ via Apple Podcasts or at plus.npr.org. Email us at considerthis@npr.org.This episode was produced by Michael Levitt, with audio engineering by Zo vanGinhoven. It was edited by Sarah Handel, Scott Hensley and Amina Khan. Our executive producer is Sami Yenigun.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Are you concerned about NIH funding for your research? Dr. Meg Bouvier, founder of Bouvier Grant Group, shares encouraging news: despite proposed cuts, Congress has protected NIH's nearly $50 billion budget with strong bipartisan support.  In this episode, Dr. Meg Bouvier explains how researchers can adapt their grant applications by reframing language to emphasize disease burden reduction and cost savings—without changing their core research direction. With nearly four decades of experience, including working as a staff writer for Francis Collins, she dispels myths about "forbidden terms" and offers practical strategies for navigating today's funding climate.  We also explore Meg's journey building a successful consulting business by hiring the right team. Her director of operations handles everything except Meg's zone of genius—allowing her to focus entirely on training researchers and analyzing grants. This principle applies whether you're pursuing funding or building a medical practice: stay at the top of your licensure and delegate everything else.  Key topics covered: NIH budget reality check, grant application strategies, team building, research development resources, adapting to funding climate changes, and balancing business ownership with meaningful work.  Read the full show notes, memorable quotes, and key takeaways.  

Eric welcomes Council on Foreign Relations President Mike Froman to discuss CFR's latest task force report on U.S. economic security. They explore the importance of AI, quantum computing and biotechnology as foundational technologies in today's strategic competition, the effort that China is investing in these technologies, and the market failures that have led the U.S. to underinvest in quantum and biotech. The conversation also covers supply chain vulnerabilities, human capital shortfalls in key areas of technology, and the tension in the Trump administration's effort to address China's growing technological dominance while simultaneously cutting funding for basic research at the NSF, NIH, and other institutions. U.S. Economic Security: Winning the Race for Tomorrow's Technologies: https://www.cfr.org/task-force-report/us-economic-security Mike Froman on Substack: https://mikefroman.substack.com/ Shield of the Republic is a Bulwark podcast co-sponsored by the Miller Center of Public Affairs at the University of Virginia.

Dr. Ryan Gober, Medical Science Liaison at Electromedical Products International (EPI). Dr. Gober shares his insights on the science behind Alpha-Stim, its clinical applications for anxiety, insomnia, and pain, and the role of non-invasive brain stimulation in mental health treatment.Electromedical Products International (EPI) is a medical device company specializing in developing neuromodulation technologies including its flagship product, Alpha-Stim.   Alpha-Stim is a FDA cleared medical device which utilizes a form of non-invasive electrical stimulation  to treat symptoms of anxiety, insomnia, and pain.  Ryan Gober is a Medical Science Liaison with EPI's Medical Affairs team responsible for sharing scientific and clinical information related to the Alpha-Stim device.  Prior to joining EPI, Ryan completed an NIH research fellowship followed by a PhD in translational neuroscience where he performed research on behavioral health conditions and developed an interest in non-pharmacological options for treating mental health conditions, leading him to join Alpha-Stim.  SHOWNOTES: 

As 2025 closes, biopharma and healthcare are learning to live on shifting ground. In this special year-end episode of "The Top Line," Fierce reporters take stock of a year defined by federal research cuts, vaccine policy fights and leadership churn at the FDA, then push the conversation forward into the questions that will shape 2026. The through line is that uncertainty has become an operating environment, and the industry is recalibrating in real time. Fierce Biotech’s Gabrielle Masson, joined by Darren Incorvia, traces how funding decisions can narrow the pipeline years before the consequences are visible. Fierce Pharma’s Fraiser Kansteiner sits down with Angus Liu and Eric Sagonowsky to unpack the new center of gravity inside federal agencies, where vaccine recommendations, review norms and new FDA pilots are colliding with questions about capacity and outside influence. From there, Ben Adams and James Waldron bring the lens to Europe, where Jefferies in London captured a cautiously optimistic market still wrestling with tariffs, pricing pressure and investment hesitation. The episode closes with Fierce Healthcare’s Heather Landi and Paige Minemyer sharing their outlook on 2026, from the fight over ACA subsidies and Medicaid headwinds to the next phase of AI adoption, where the promise is real but the payoff may be slower, messier and more uneven than the hype suggests. To learn more about the topics in this episode: 'Unprecedented turmoil' engulfing FDA threatens public health: mRNA coalition speaks out FDA names Tracy Beth Høeg, fresh from vaccine safety probe, as acting head of drug center A dozen former FDA commissioners blast Prasad's proposed vaccine policy changes In letter to Makary, biotech CEOs push for FDA stability and say volatility threatens US innovation NIH grant cuts have disrupted hundreds of clinical trials, study finds 'Alternative history' of the NIH shows how a 40% budget cut may thwart new medicines House passes healthcare affordability bill without subsidy extension AMA: A look at concentration in commercial insurance, MA markets 2025 Outlook: Hospital finances show signs of stability, but rising costs will be a major headwind See omnystudio.com/listener for privacy information.

Kevin Hall, Ph.D., is a physicist-turned-nutrition scientist whose rigorous research has upended some of our most sacrosanct beliefs about metabolism, dieting, and weight loss. This conversation explores why diets fail, the truth behind the "slow metabolism" myth, how ultra-processed foods hijack our biology, and why the 800-pound gorilla driving the obesity epidemic isn't willpower—it's our toxic food environment. He also opens up about his decision to leave the NIH after 20 years due to political interference with his research. Kevin is an honest actor, always trying to set matters to rights amidst a hurricane of nutritional misinformation. Enjoy! Show notes + MORE Watch on YouTubeNewsletter Sign-Up Today's Sponsors: On: High-performance shoes & apparel crafted for comfort and style

Dr. Marissa Russo trained to become a cancer biologist. She spent four years studying one of the deadliest brain tumors in adults and built her entire research career around a simple, urgent goal: open her own lab and improve the odds for patients with almost no shot at survival. In 2024 she applied for an F31 diversity grant through the NIH. The reviewers liked her work. Her resubmission was strong. Then the grant system started glitching. Dates vanished. Study sections disappeared. Emails went silent. When she finally reached a program officer, the message was clear: scrub the DEI language, withdraw, and resubmit. She rewrote the application in ten days. It failed. She had to start over. Again. This time with her identity erased.Marissa left the lab. She found new purpose as a science communicator, working at STAT News through the AAAS Mass Media Fellowship. Her story captures what happens when talent collides with institutional sabotage. Not every scientist gets to choose a Plan B. She made hers count.RELATED LINKSMarissa Russo at STAT NewsNIH F31 grant story in STATAAAS Mass Media FellowshipContact Marissa RussoFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Join Josh Webster and Dr. Mark Edney as they break down the AUA's most significant health policy victories of 2025. From the historic removal of the FDA's black box warning on low-dose estrogen to progress on Medicare payment reform, NIH research funding, prior authorization relief, telehealth expansion, and prostate cancer screening advocacy, 2025 was a big year for the AUA. This special AUANews Inside Tract episode brings listeners inside the halls of Congress, highlights the AUA's growing influence in federal and state policy, outlines what's next, and how members can stay engaged as momentum builds for 2026.

In this episode, Dr. Paul Turek and I are talking about the latest research on isotretinoin aka Accutane (a medication traditionally used for acne) and its potential to restore sperm production in men who previously had no options. Our discussion explores the science behind this therapy, the real-world impact for patients, and what this means for the future of male fertility treatments. We also touch on the broader landscape of advances in male reproductive health, including the role of AI and the importance of early, expert evaluation. Read the full show notes on Dr. Aimee's website. In this episode, we cover: The story behind the recent study on isotretinoin and male infertility How vitamin A derivatives play a crucial role in sperm production The specifics of Dr. Turek's clinical trial with isotretinoin and its promising results Safety considerations and misconceptions about isotretinoin use in men How this therapy fits into the broader landscape of male fertility treatments The future of male fertility, including AI-driven advances and at-home diagnostics Practical advice for men and couples navigating infertility Resources: Turek Clinic Isotretinoin Study at NIH website Talk with Turek Podcast Contact Turek Clinic: San Francisco (415-392-3200), Los Angeles (310-499-9299) Egg Whisperer Show on YouTube Egg Whisperer Show on Spotify Do you have questions about IVF? Click here to join Dr. Aimee for The IVF Class. The next live class call is on Monday, January 12, 2026, at 4 pm PST, where I'll explain IVF and Egg Freezing, and answer your questions live on Zoom. Other ways to connect with me: Visit my YouTube channel for more fertility tipsSubscribe to the newsletter to get updatesJoin Egg Whisperer SchoolRequest a Consultation with Dr. Aimee Dr. Aimee Eyvazzadeh is one of America's most well-known fertility doctors. Her success rate at baby-making gives future parents hope when all hope is lost. She pioneered the TUSHY Method and BALLS Method to decrease your time to pregnancy. Learn more about the TUSHY Method and find a wealth of fertility resources at www.draimee.org.

The lymphatic system, or lymphoid system, is one of the components of the circulatory system, and it serves a critical role in both immune function and surplus extracellular fluid drainage.  Components of the lymphatic system include lymph, lymphatic vessels and plexuses, lymph nodes, lymphatic cells, and a variety of lymphoid organs. The pattern and form of lymphatic channels are more variable and complex but generally parallel those of the peripheral vascular system. The lymphatic system partly functions to convey lymphatic fluid, or lymph, through a network of lymphatic channels, filter lymphatic fluid through lymph nodes and return lymphatic fluid to the bloodstream, where it is eventually eliminated. Nearly all body organs, regions, and systems have lymphatic channels to collect the various byproducts that require elimination . Liver and intestinal lymphatics produce about 80% of the volume of lymph in the body. Notable territories of the body that do not appear to contain lymphatics include the bone marrow, epidermis, as well as other tissues where blood vessels are absent. The central nervous system was long considered to be absent of lymphatic vessels until they were recently identified in the cranial meninges. Moreover, a vessel appearing to have lymphatic features was also discovered in the eye. The lymphatic system is critical in a clinical context, particularly given that it is a major route for cancer metastasis and that the inflammation of lymphatic vessels and lymph nodes is an indicator of pathology.  Structure The lymphatic system includes numerous structural components, including lymphatic capillaries, afferent lymphatic vessels, lymph nodes, efferent lymphatic vessels, and various lymphoid organs.  Lymphatic capillaries are tiny, thin-walled vessels that originate blindly within the extracellular space of various tissues. Lymphatic capillaries tend to be larger in diameter than blood capillaries and are interspersed among them to enhance their ability to collect interstitial fluid efficiently. They are critical in the drainage of extracellular fluid and allow this fluid to enter the closed capillaries but not exit due to their unique morphology. Lymphatic capillaries at their blind ends are composed of a thin endothelium without a basement membrane. The endothelial cells at the closed end of the capillary overlap but shift to open the capillary end when interstitial fluid pressure is greater than intra-capillary pressure. This process permits lymphocytes, interstitial fluid, bacteria, cellular debris, plasma proteins, and other cells to enter the lymphatic capillaries. Special lymphatic capillaries called lacteals exist in the small intestine to contribute to the absorption of dietary fats. Lymphatics in the liver contribute to a specialized role in transporting hepatic proteins into the bloodstream. The lymphatic capillaries of the body form large networks of channels called lymphatic plexuses and converge to form larger lymphatic vessels. Lymphatic vessels convey lymph, or lymphatic fluid, through their channels. Afferent (toward) lymphatic vessels convey unfiltered lymphatic fluid from the body tissues to the lymph nodes, and efferent (away) lymphatic vessels convey filtered lymphatic fluid from lymph nodes to subsequent lymph nodes or into the venous system. The various efferent lymphatic vessels in the body eventually converge to form two major lymphatic channels: the right lymphatic duct and the thoracic duct.  The right lymphatic duct drains most of the right upper quadrant of the body, including the right upper trunk, right upper extremity, and right head and neck. The right lymphatic trunk is a visible channel in the right cervical region just anterior to the anterior scalene muscle. Its origin and termination are variable in morphology, typically forming as the convergence of the right bronchomediastinal, jugular, and subclavian trunks, extending 1 to 2 centimeters in length before returning its contents to the systemic circulation at the junction of the right internal jugular, subclavian, and/or brachiocephalic veins.  The thoracic duct, also known as the left lymphatic duct or van Hoorne's canal, is the largest of the body's lymphatic channels. It drains most of the body except for the territory of the right superior thorax, head, neck, and upper extremity served by the right lymphatic duct. The thoracic duct is a thin-walled tubular vessel measuring 2 to 6 mm in diameter. The length of the duct ranges from 36 to 45 cm. The thoracic duct is highly variable in form but typically arises in the abdomen at the superior aspect of the cisterna chyli, around the level of the twelfth thoracic vertebra (T12). The cisterna chyli, from which it extends, is an expanded lymphatic sac that forms at the convergence of the intestinal and lumbar lymphatic trunks extending along the L1-L2 vertebral levels. The cisterna chyli is present in approximately 40-60% of the population, and in its absence, the intestinal and lumbar lymphatic trunks communicate directly with the thoracic duct at the T12 level. As a result, the thoracic duct receives lymphatic fluid from the lumbar lymphatic trunks and chyle, composed of lymphatic fluid and emulsified fats, from the intestinal lymphatic trunk. Initially, the thoracic duct is located just to the right of the midline and posterior to the aorta. It exits the abdomen and enters the thorax via the aortic hiatus formed by the right and left crura of the diaphragm, side by side with the aorta. The thoracic duct then ascends in the thoracic cavity just anterior and to the right of the vertebral column between the aorta and azygos vein. At about the level of the fifth thoracic vertebra (T5), the thoracic duct typically crosses to the left of the vertebral column and posterior to the esophagus. From here, it ascends vertically and usually empties its contents into the junction of the left subclavian and left internal jugular veins in the cervical region. To ensure that lymph does not flow backward, collecting lymphatic vessels and larger lymphatic vessels have one-way valves. These valves are not present in the lymphatic capillaries. These lymphatic valves permit the continued advancement of lymph through the lymphatic vessels aided by a pressure gradient created by vascular smooth muscle, skeletal muscle contraction, and respiratory movements. However, it is important to note that lymphatic vessels also communicate with the venous system through various anastomoses. Lymph nodes are small bean-shaped tissues situated along lymphatic vessels. Lymph nodes receive lymphatic fluid from afferent lymphatic vessels and convey lymph away through efferent lymphatic vessels. Lymph nodes serve as a filter and function to monitor lymphatic fluid/blood composition, drain excess tissue fluid and leaked plasma proteins, engulf pathogens, augment an immune response, and eradicate infection. Several organs in the body are considered to be lymphoid or lymphatic organs, given their role in the production of lymphocytes. These include the bone marrow, spleen, thymus, tonsils, lymph nodes, and other tissues. Lymphoid organs can be categorized as primary or secondary lymphoid organs. Primary lymphoid organs are those that produce lymphocytes, such as the bone marrow and thymus. Bone marrow is the primary site for the production of lymphocytes. The thymus is a glandular organ located anterior to the pericardium. It serves to mature and develop T cells, or thymus cell lymphocytes, in response to an inflammatory process or pathology. As individuals age, both their bone marrow and thymus reduce and accumulate fat. Secondary lymphoid organs serve as territories in which immune cells function and include the spleen, tonsils, lymph nodes, and various mucous membranes, such as in the intestines. The spleen is a purplish, fist-sized organ in the left upper abdominal quadrant that contributes to immune function by serving as a blood filter, storing lymphocytes within its white pulp, and being a site for an adaptive immune response to antigens. The lingual tonsils, palatine tonsils, and pharyngeal tonsils, or adenoids, work to prevent pathogens from entering the body. Mucous membranes in the gastrointestinal, respiratory, and genitourinary systems also function to prevent pathogens from entering the body. Lymph Lymphatic fluid, or lymph, is similar to blood plasma and tends to be watery, transparent, and yellowish in appearance. Extracellular fluid leaks out of the blood capillary walls because of pressure exerted by the heart or osmotic pressure at the cellular level. As the interstitial fluid accumulates, it is picked up by the tiny lymphatic capillaries along with other substances to form lymph. This fluid then passes through the lymphatic vessels and lymph nodes and finally enters the venous circulation. As the lymph passes through the lymph nodes, both monocytes and lymphocytes enter it.  Lymph is composed primarily of interstitial fluid with variable amounts of lymphocytes, bacteria, cellular debris, plasma proteins, and other cells. In the GI tract, lymphatic fluid is called chyle and has a milk-like appearance that is chiefly due to the presence of cholesterol, glycerol, fatty acids, and other fat products. The vessels that transport the lymphatic fluid from the GI tract are known as lacteals. Embryology The development of the lymphatic system is known from both human and animal, especially mouse studies. The lymphatic vessels form after the development of blood vessels, around six weeks post-fertilization. The endothelial cells that serve as precursors to the lymphatics arise from the embryonic cardinal veins. The process by which lymphatic vessels form is similar to that of the blood vessels and produces lymphatic-venous and intra-lymphatic anastomoses, but diverse origins exist for components of lymphatic vessel formation in different regions.  Six primary lymph sacs develop and are apparent about eight weeks post-fertilization. These include, from caudal to cranial, one cisterna chyli, one retroperitoneal lymph sac, two iliac lymph sacs, and two jugular lymph sacs. The jugular lymph sacs are the first to develop, initially appearing next to the jugular part of the cardinal vein. Lymphatic vessels then form adjacent to the blood vessels and connect the various lymph sacs. The lymphatic vessels primarily arise from the lymph sacs through the process of self-proliferation and polarized sprouting.  Stem/progenitor cells play a huge role in forming lymphatic tissues and vessels by contributing to sustained growth and postnatally differentiating into lymphatic endothelial cells. Lymphatic channels from the developing gut connect with the retroperitoneal lymph sac and the cisterna chyli, situated just posteriorly. The lymphatic channels of the lower extremities and inferior trunk communicate with the iliac lymph sacs. Finally, lymphatic channels in the head, neck and upper extremities drain to the jugular lymph sacs. Additionally, a right and left thoracic duct form and connect the cisterna chyli with the jugular lymph sacs and form anastomoses that eventually produce the typical adult form. The lymph sacs then produce groups of lymph nodes in the fetal period. Migrating mesenchyme enters the lymph sacs and produces lymphatic networks, connective tissue, and other layers of the lymph nodes. Function The lymphatic system's primary function is to balance the volume of interstitial fluid and convey it and excess protein molecules into the venous circulation. The lymphatic system is also important in immune surveillance, defending the body against foreign particles and microorganisms. It does so by conveying antigens and leukocytes to lymph nodes, where antigen-primed and targeted lymphocytes and other immune cells are conveyed into the lymphatic vessels and blood vessels. In addition, the system has a role in the absorption of fat-soluble vitamins and fatty substances in the gut via the gastrointestinal tract's lacteals within the villi and the transport of this material into the venous circulation.  Newly recognized lymphatic vessels are visible in the meninges relating to cerebrospinal fluid (CSF) outflow from the central nervous system. Finally, lymphatics may play a role in the clearance of ocular fluid via the lymphatic-like Schlemm canals. Clinical Significance Leaks of lymphatic fluid occur when the lymphatic vessels are damaged. In the abdomen, lymphatic vessel damage may occur during surgery, especially during retroperitoneal procedures such as repairing an abdominal aortic aneurysm. These leaks tend to be mild, and the vessels in the peritoneum and mesentery eventually absorb the lymphatic fluid or chyle. However, when the thoracic duct is injured in the chest, the chyle leak can be extensive. In most cases, conservative care with a no-fat diet (medium chain triglycerides) or total parenteral nutrition is unsuccessful. In most cases, if the injury to the thoracic duct was surgical, a surgical procedure is required to tie off the duct. If the thoracic duct is injured in the cervical region, then inserting a drainage tube and adopting a low-fat diet will help seal the leak. However, thoracic duct injury in the chest cavity usually requires drainage and surgery. It is rare for the thoracic segment of the thoracic duct to seal on its own. In terms of accumulation of chyle in the thorax (i.e., chylothorax), if a patient has an injury to the thoracic duct in the thorax below the T5 vertebral level, then fluid will collect in only the right pleural cavity. If the injury is to the thoracic duct in the thorax above the T5 vertebral level, then fluid will appear in both pleural cavities.   Other Issues The lymphatic system is prone to disorders like the venous and arterial circulatory systems. Developmental or functional defects of the lymphatic system cause lymphedema. When this occurs, the lymphatic system is unable to sufficiently drain lymphatic fluid resulting in its accumulation and swelling of the territory. Lymphedema, this swelling due to the accumulation of lymph, is classified as primary or secondary. Primary lymphedema is an inherited disorder where the lymphatic system development has been disrupted, causing absent or malformed lymphatic tissues. This condition often presents soon after birth, but some conditions may present later in life (e.g., at puberty or later adulthood). There are no effective treatments for primary lymphedema. Past surgical treatments were found to be mutilating and are no longer implemented. The present-day treatment revolves around compression stockings, pumps, and constrictive garments. Secondary lymphedema is an acquired disorder involving lymphatic system dysfunction that may result from many causes, including cancer, infection, trauma, or surgery. The treatment of secondary lymphedema depends on the cause. Oncological and other surgeries may result in secondary lymphedema due to the removal or biopsy of lymph nodes or lymphatic vessels. Non-surgical lymphedema may result from malignancies, obstruction within the lymphatic system, infection, or deep vein thrombosis. In most cases of obstructive secondary lymphedema, the drainage will resume if the inciting cause is removed, although some individuals may need to wear compressive stockings permanently. Also, physical therapy may help alleviate lymphedema when the extremities are involved. There is no absolute cure for lymphedema, but diagnosis and careful management can help to minimize complications. Lymphomas are cancers that arise from the cells of the lymphatic system. There are numerous types of lymphoma, but they are grouped into Hodgkin lymphoma and non-Hodgkin lymphoma. Lymphomas usually arise from the malignant transformation of specific lymphocytes in the lymphatic vessels or lymph nodes in the gastrointestinal tract, neck, axilla, or groin. Symptoms of lymphoma may include night sweats, fever, fatigue, itching, and weight loss. Cancers originating outside of the lymphatic system often spread via the lymphatic vessels and may involve regional lymph nodes serving the impacted organs or tissues. Lymphadenitis occurs when the lymph nodes become inflamed or enlarged. The cause is usually an adjacent bacterial infection but may also involve viruses or fungi. The lymph nodes usually enlarge and become tender. Lymphatic filariasis, or elephantiasis, is a very common mosquito-borne disorder caused by a parasite found in tropical and subtropical areas of the world, including Africa, Asia, the Pacific, the Caribbean, and South America. This condition involves parasitic microscopic nematodes (roundworms) that infect the lymphatic system and rapidly multiply and disrupt lymphatic function. Many infected individuals may have no outward symptoms, although the kidneys and lymphatic tissues may be damaged and dysfunctional. Symptomatic individuals may present with disfigurement caused by significant lymphedema and elephantiasis (thickening of the skin, particularly the extremities). The parasite may also cause hydrocele, an enlargement of the scrotum due to the accumulation of fluid, which may result from obstruction of the lymph nodes or vessels in the groin. Individuals presenting with symptoms have poorly draining lymphatics, often involving the extremities, resulting in huge extremities and marked disability. Lymphatic filariasis is the most common cause of disfigurement in the world, and it is the second most common cause of long-term disability.  (credits: NIH)

In this educational, refreshing, and beautifully hopeful episode, Wren, the creator of the Living Our Breast Lives Podcast, is joined by the incredible Metastatic Breast Cancer Thriver, Carolyn Leigh, the President of North Star Cancer Advocacy.In 2018, she was the third member of her family to be diagnosed with metastatic breast cancer, including her mother and uncle. After her metastatic diagnosis, she spent years studying the latest scientific understandings about the immune system and immunotherapies for cancer before launching North Star Cancer Advocacy in 2022 with the aim of providing information to the community and advocating for vast increases in NIH funding. The North Star Board of Directors and the MBC community recently raised $100k to further the research of combining Natural Killer cells (immune system cells) and one of the most promising breast cancer drugs in preclinical development, ErSO-TFPy.In this episode, join me as Carolyn breaks down: - How the inspirational Judy Perkins and TILs therapy reshaped her belief in what's possible- The moment she decided to found North Star- A simple breakdown of MHC I expression and why some immunotherapies succeed while others don't- A crash course in how immunotherapy actually works inside the body- Her mission to raise six figures for immunotherapy-driven clinical trials — and what real success would look like - How and where to access immunotherapy clinical trials- A raw conversation about allyship, momentum, and why the MBC movement can't depend solely on those living with the diseaseCarolyn isn't just an MBC advocate… she's a brilliant mind, a fierce researcher, the president of the North Star Cancer Research Foundation, and a woman determined to change the future of metastatic breast cancer!Living Our Breast Lives Information:Email: livingourbreastlivespodcast1@gmail.comInstagram: @livingourbreastlivesFounder: Wren MorrobelPersonal Instagram: @wren_morrPodcast Guest Speaker: Carolyn Leigh's Information:Email: NorthStarCancerAdvocacy@yahoo.comInstagram: @north.star.cancer.advocacy@north.star.cancer.researchFacebook: North Star Cancer Research FoundationWebsite: NorthStarCancerResearch.orgCRI Clinical Trial Finder:https://cri.careboxhealth.com/en-US/

Dr. Mary Talley Bowden, a well-regarded ENT specialist, became one of the most polarizing figures in American medicine after refusing to fall in line during COVID. When her off-label use of ivermectin went public, the backlash was immediate: her hospital suspended her, the medical board came after her, and she was thrust into a national firestorm. In this episode, she lays out the blueprint she says was used to punish dissenting physicians—how hospital systems, public-health agencies, and industry interests closed ranks to enforce a single narrative. She breaks down the conflicts of interest baked into the modern “medical-industrial complex,” and why she decided to fight rather than fold. From vaccine-injury cases to mandate battles to the unprecedented wave of medical censorship, Dr. Bowden pulls no punches. She takes aim at the NIH, FDA, major hospital systems, and the Biden administration—exposing what she sees as a system more interested in profit, control, and compliance than patient care.

Dr. Mary Talley Bowden, a well-regarded ENT specialist, became one of the most polarizing figures in American medicine after refusing to fall in line during COVID. When her off-label use of ivermectin went public, the backlash was immediate: her hospital suspended her, the medical board came after her, and she was thrust into a national firestorm.In this episode, she lays out the blueprint she says was used to punish dissenting physicians—how hospital systems, public-health agencies, and industry interests closed ranks to enforce a single narrative. She breaks down the conflicts of interest baked into the modern “medical-industrial complex,” and why she decided to fight rather than fold.From vaccine-injury cases to mandate battles to the unprecedented wave of medical censorship, Dr. Bowden pulls no punches. She takes aim at the NIH, FDA, major hospital systems, and the Biden administration—exposing what she sees as a system more interested in profit, control, and compliance than patient care.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The National Institutes of Health have historically funded scientists to find cures for diseases and protect public health. NIH funding has led to the discovery of immune therapies for cancer, antiviral treatments and prevention of HIV, and ground-breaking research into memory loss and Alzheimer's disease. After a year of funding cuts and freezes that have rocked the medical research field to its core, we catch up with leading researchers at the University of California to talk about the impact this has had on their work and our ability to fight humanity's most puzzling illnesses. Guests: Monica Gandhi, infectious disease expert and professor of medicine at University of California San Francisco - she is the director of the UCSF Gladstone Center for AIDS Research and the medical director of the San Francisco General Hospital HIV Clinic, Ward 86 Pamela Munster, professor of medicine at the University of California San Francisco; co-director, Center for BRCA Research, Medical Oncology; distinguished professor in Hereditary Cancer Research Megan Molteni, science writer, STAT News Joel Spencer, associate professor of Bioengineering, University of California Merced - his lab uses funding from NIH to study the thymus, with implications for cancer treatment and healthy aging Learn more about your ad choices. Visit megaphone.fm/adchoices

Episode 5 of Standard Deviation with Oliver Bogler on the Out of Patients podcast feed pulls you straight into the story of Dr Ethan Moitra, a psychologist who fights for LGBTQ mental health while the system throws every obstacle it can find at him.Ethan built a study that tracked how COVID 19 tore through an already vulnerable community. He secured an NIH grant. He built a team. He reached 180 participants. Then he opened an email on a Saturday and learned that Washington had erased his work with one sentence about taxpayer priorities. The funding vanished. The timeline collapsed. His team scattered. Participants who trusted him sat in limbo.A federal court eventually forced the government to reinstate the grant, but the damage stayed baked into the process. Ethan had to push through months of paperwork while his university kept the original deadline as if the shutdown had not happened. The system handed him a win that felt like a warning.I brought Ethan on because his story shows how politics reaches into science and punishes the people who serve communities already carrying too much trauma. His honesty lands hard because he names the fear now spreading across academia and how young scientists question whether they can afford to care about the wrong population.You will hear what this ordeal did to him, what it cost his team, and why he refuses to walk away.RELATED LINKSFaculty PageNIH Grant DetailsScientific PresentationBoston Globe CoverageFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode of "Swallow Your Pride," host Theresa Richard brings together a panel of NIH-funded researchers from the University of North Carolina at Chapel Hill to unpack the complexity of diagnosing and treating motor speech disorders after left-hemisphere stroke. Theresa Richard guides a conversation that demystifies the overlap between apraxia of speech, dysarthria, and aphasia, highlights the challenges clinicians face in acute and subacute care, and introduces innovative assessment tools designed to bring more objectivity and clarity to real-world practice. The team shares emerging findings, practical insights for SLPs across the continuum of care, and a look at how new perceptual and acoustic measures may shape the future of stroke-related speech assessment. Links mentioned in the show: UNC Center for Aphasia and Related Disorder's Lab website (includes information on our research and helpful therapy resources regarding aphasia, communication partner training, and aphasia-friendly print materials): https://www.med.unc.edu/healthsciences/sphs/card/ Tools Available for Speech Therapists for Assessment... Word Information Measure and Moving Average Type Token Ratio (Shiny App): https://unccard.shinyapps.io/WIM_MATTR/ Word Complexity Measure (Shiny App): https://unccard.shinyapps.io/shiny-woRdcomplex-2/ Word Complexity Measure Ratio (Shiny App): https://unccard.shinyapps.io/shiny-wcmRatio/ The post 385 – Navigating the Complexities of Speech Disorders After Stroke: A Deep Dive into Current Research and Practices appeared first on Swallow Your Pride Podcast.

Harvard president Alan Garber and National Institutes of Health head Jay Bhattacharya are two main characters at the heart of the national fight over the future of academia. Alan Garber has been cast as the defender of academic freedom and democracy; Jay Bhattacharya is Donald Trump's pick to lead the NIH, the agency withholding billions of dollars in research grants from Harvard. Oddly enough, the two men go way back: Garber was Bhattacharya's undergraduate thesis advisor and mentor in the late 1980s. This episode tells the story of how the two men found themselves adversaries — and what it means for the future of science. Find more On the Media every week, here: https://podcasts.apple.com/us/podcast/on-the-media/id73330715Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Full Show Notes: https://bengreenfieldlife.com/drandrew Dr. Andrew Koutnik is a research scientist whose career bridges cutting-edge science, elite performance, and personal experience living with type 1 diabetes for over 17 years. His work focuses on how nutrition, metabolism, and lifestyle can be leveraged to maximize human health, performance, and resilience across diverse conditions—from chronic disease to extreme environments. Dr. Andrew Koutnik earned his Ph.D. in Medical Sciences (Molecular Pharmacology and Physiology) from the University of South Florida Morsani College of Medicine. Prior to joining FSU, Dr. Andrew Koutnik served as a Faculty/Principal Investigator at Sansum Diabetes Research Institute and Florida Institute for Human and Machine Cognition. His research has spanned over $70,000,000 in research funding, including NASA missions, U.S. Special Operations Command, Defense Advanced Research Projects, Office of Naval Research, Department of Defense, and NIH-funded clinical trials Episode Sponsors: LVLUP Health: I trust and recommend LVLUP Health for your peptide needs as they third-party test every single batch of their peptides to ensure you’re getting exactly what you pay for and the results you’re after! Head over to lvluphealth.com/BGL and use code BEN15 for a special discount on their game-changing range of products. Ketone-IQ: Ketones are a uniquely powerful macronutrient that can cross the blood-brain barrier and increase brain energy and efficiency. With a daily dose of Ketone-IQ, you'll notice a radical boost in focus, endurance, and performance. Save 30% off your first subscription order of Ketone-IQ at Ketone.com/BENG. CAROL Bike: The science is clear—CAROL Bike is your ticket to a healthier, more vibrant life. And for a limited time, you can get $100 off yours with the code BEN. Don't wait any longer, join over 25,000 riders and visit carolbike.com/ben today. Sunlighten: Sunlighten's patented infrared sauna technology delivers the highest quality near, mid, and far infrared wavelengths to reduce inflammation, boost mitochondrial function, enhance detox pathways, and optimize recovery—backed by 25+ years of clinically proven, non-toxic innovation. Save up to $1,400 at Sunlighten.com/BEN with code BEN. Gameday Men’s Health: Gameday Men's Health offers science-backed, physician-led men's health optimization with personalized protocols for testosterone, peptide therapy, ED treatment, and more—helping you perform at your best whether you're training hard or keeping up with life. Visit gamedaymenshealth.com/bengreenfield for a free testosterone test and consultation at a clinic near you. Boundless Bar: If you’re ready to fuel workouts, sharpen your focus, and support whole-body vitality, grab your Boundless Bars now at boundlessbar.com —and save 10% when you sign up for a Boundless Bar subscription.See omnystudio.com/listener for privacy information.